<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:api="http://www.symplectic.co.uk/publications/api"><api:schema-version>4.9</api:schema-version><category scheme="http://www.symplectic.co.uk/publications/atom/feeds/" term="relationship-list" label="Relationship list"/><id>tag:elements@oxford,4.10:/elements-api/v4.9/feeds/users/4063/relationships?types=8</id><updated>2014-11-10T10:21:41.2435943+00:00</updated><generator uri="https://oxris.ox.ac.uk/" version="4.10">Symplectic Elements</generator><icon>https://oxris.ox.ac.uk:8091/elements-api/v4.9/symplectic.ico</icon><rights>This data is the property of the Organisation, and can only be used with permission.</rights><subtitle type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>This feed represents page <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full">1</a> of 2 listing a total of 44 relationship results from the following search query: <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full">https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full</a></p></div></subtitle><api:pagination results-count="44" items-per-page="25"><api:page position="this" number="1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full"/><api:page position="first" number="1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full"/><api:page position="next" number="2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;page=2&amp;detail=full"/><api:page position="last" number="2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;page=2&amp;detail=full"/></api:pagination><link type="application/atom+xml" rel="self" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full"/><link type="application/atom+xml" rel="first" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;detail=full"/><link type="application/atom+xml" rel="next" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;page=2&amp;detail=full"/><link type="application/atom+xml" rel="last" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063/relationships?types=8&amp;page=2&amp;detail=full"/><title>Relationships of the user: MULLER-KNAPP, Susanne</title><author><name>Symplectic Elements at Oxford</name></author><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/694290</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-08-22T12:54:25.203+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/694290"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/478300"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/478300">Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.</a></p></div></content><api:relationship id="694290" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/694290"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="478300" last-modified-when="2014-10-30T17:30:07.07+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/478300" created-when="2014-08-07T17:41:13.35+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-01-01</api:reporting-date-1><api:records><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:25097667" is-preferred-record="true"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>BACKGROUND: Acetylation of lysine residues in histone tails plays an important role in the regulation of gene transcription. Bromdomains are the readers of acetylated histone marks, and, consequently, bromodomain-containing proteins have a variety of chromatin-related functions. Moreover, they are increasingly being recognised as important mediators of a wide range of diseases. The first potent and selective bromodomain inhibitors are beginning to be described, but the diverse or unknown functions of bromodomain-containing proteins present challenges to systematically demonstrating cellular efficacy and selectivity for these inhibitors. Here we assess the viability of fluorescence recovery after photobleaching (FRAP) assays as a target agnostic method for the direct visualisation of an on-target effect of bromodomain inhibitors in living cells. RESULTS: Mutation of a conserved asparagine crucial for binding to acetylated lysines in the bromodomains of BRD3, BRD4 and TRIM24 all resulted in reduction of FRAP recovery times, indicating loss of or significantly reduced binding to acetylated chromatin, as did the addition of known inhibitors. Significant differences between wild type and bromodomain mutants for ATAD2, BAZ2A, BRD1, BRD7, GCN5L2, SMARCA2 and ZMYND11 required the addition of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) to amplify the binding contribution of the bromodomain. Under these conditions, known inhibitors decreased FRAP recovery times back to mutant control levels. Mutation of the bromodomain did not alter FRAP recovery times for full-length CREBBP, even in the presence of SAHA, indicating that other domains are primarily responsible for anchoring CREBBP to chromatin. However, FRAP assays with multimerised CREBBP bromodomains resulted in a good assay to assess the efficacy of bromodomain inhibitors to this target. The bromodomain and extraterminal protein inhibitor PFI-1 was inactive against other bromodomain targets, demonstrating the specificity of the method. CONCLUSIONS: Viable FRAP assays were established for 11 representative bromodomain-containing proteins that broadly cover the bromodomain phylogenetic tree. Addition of SAHA can overcome weak binding to chromatin, and the use of tandem bromodomain constructs can eliminate masking effects of other chromatin binding domains. Together, these results demonstrate that FRAP assays offer a potentially pan-bromodomain method for generating cell-based assays, allowing the testing of compounds with respect to cell permeability, on-target efficacy and selectivity.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK ; Current address: Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, Oxford OX3 7LD, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>JP</api:initials></api:person><api:person><api:last-name>Strain-Damerell</api:last-name><api:initials>C</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>AC</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1186/1756-8935-7-14</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1186/1756-8935-7-14"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1186/1756-8935-7-14"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1756-8935</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1756-8935"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">25097667</api:identifier><api:identifier scheme="pmc">PMC4115480</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Epigenetics &amp; chromatin</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Electronic-eCollection</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>14</api:begin-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>7</api:text></api:field><api:files><api:file proprietary-id="http://europepmc.org/articles/PMC4115480?pdf=render"><api:file-url>http://europepmc.org/articles/PMC4115480?pdf=render</api:file-url><api:extension>pdf</api:extension></api:file></api:files></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="25097667"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Acetylation of lysine residues in histone tails plays an important role in the regulation of gene transcription. Bromdomains are the readers of acetylated histone marks, and, consequently, bromodomain-containing proteins have a variety of chromatin-related functions. Moreover, they are increasingly being recognised as important mediators of a wide range of diseases. The first potent and selective bromodomain inhibitors are beginning to be described, but the diverse or unknown functions of bromodomain-containing proteins present challenges to systematically demonstrating cellular efficacy and selectivity for these inhibitors. Here we assess the viability of fluorescence recovery after photobleaching (FRAP) assays as a target agnostic method for the direct visualisation of an on-target effect of bromodomain inhibitors in living cells.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK ; Current address: Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, Oxford OX3 7LD, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Current address: Nanotether Discovery Sciences Ltd, Museum Avenue, Cardiff University, Cardiff CF10 3AX, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>JP</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="full">Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Strain-Damerell</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>AC</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="full">Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada ; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK ; Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, UK.</api:line></api:address></api:addresses></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/25097667</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1186/1756-8935-7-14</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1186/1756-8935-7-14"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1186/1756-8935-7-14"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1756-8935</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1756-8935"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC4115480</api:identifier></api:identifiers></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Epigenetics Chromatin</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Bromodomain</api:keyword><api:keyword>Cell-based assay</api:keyword><api:keyword>Confocal microscopy</api:keyword><api:keyword>Epigenetics</api:keyword><api:keyword>Fluorescence recovery after photobleaching</api:keyword><api:keyword>Histone acetylation</api:keyword><api:keyword>Small-molecule inhibitor</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>14</api:begin-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>1756-8935-7-14</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>7</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000339837300001"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>J-P</api:initials></api:person><api:person><api:last-name>Strain-Damerell</api:last-name><api:initials>C</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>A-C</api:initials><api:identifiers><api:identifier scheme="researcherid">E-9982-2010</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000339837300001&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1186/1756-8935-7-14</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1186/1756-8935-7-14"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1186/1756-8935-7-14"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AM4PL</api:identifier><api:identifier scheme="pubmed">25097667</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1756-8935</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1756-8935"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EPIGENETICS &amp; CHROMATIN</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Bromodomain</api:keyword><api:keyword>Cell-based assay</api:keyword><api:keyword>Confocal microscopy</api:keyword><api:keyword>Epigenetics</api:keyword><api:keyword>Fluorescence recovery after photobleaching</api:keyword><api:keyword>Histone acetylation</api:keyword><api:keyword>Small-molecule inhibitor</api:keyword></api:keywords></api:field><api:field name="number" type="text" display-name="Article number"><api:text>ARTN 14</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>7</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>7</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84904082319"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Background: Acetylation of lysine residues in histone tails plays an important role in the regulation of gene transcription. Bromdomains are the readers of acetylated histone marks, and, consequently, bromodomain-containing proteins have a variety of chromatin-related functions. Moreover, they are increasingly being recognised as important mediators of a wide range of diseases. The first potent and selective bromodomain inhibitors are beginning to be described, but the diverse or unknown functions of bromodomain-containing proteins present challenges to systematically demonstrating cellular efficacy and selectivity for these inhibitors. Here we assess the viability of fluorescence recovery after photobleaching (FRAP) assays as a target agnostic method for the direct visualisation of an on-target effect of bromodomain inhibitors in living cells. Results: Mutation of a conserved asparagine crucial for binding to acetylated lysines in the bromodomains of BRD3, BRD4 and TRIM24 all resulted in reduction of FRAP recovery times, indicating loss of or significantly reduced binding to acetylated chromatin, as did the addition of known inhibitors. Significant differences between wild type and bromodomain mutants for ATAD2, BAZ2A, BRD1, BRD7, GCN5L2, SMARCA2 and ZMYND11 required the addition of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) to amplify the binding contribution of the bromodomain. Under these conditions, known inhibitors decreased FRAP recovery times back to mutant control levels. Mutation of the bromodomain did not alter FRAP recovery times for full-length CREBBP, even in the presence of SAHA, indicating that other domains are primarily responsible for anchoring CREBBP to chromatin. However, FRAP assays with multimerised CREBBP bromodomains resulted in a good assay to assess the efficacy of bromodomain inhibitors to this target. The bromodomain and extraterminal protein inhibitor PFI-1 was inactive against other bromodomain targets, demonstrating the specificity of the method. Conclusions: Viable FRAP assays were established for 11 representative bromodomain-containing proteins that broadly cover the bromodomain phylogenetic tree. Addition of SAHA can overcome weak binding to chromatin, and the use of tandem bromodomain constructs can eliminate masking effects of other chromatin binding domains. Together, these results demonstrate that FRAP assays offer a potentially pan-bromodomain method for generating cell-based assays, allowing the testing of compounds with respect to cell permeability, on-target efficacy and selectivity. Â© 2014 Philpott et al.; licensee BioMed Central Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford</api:line><api:line type="street-address">Windmill Road</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>martin.philpott@ndorms.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>catherine.rogers@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">56198186100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>clarence.yapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">55790772400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nanotether Discovery Sciences Ltd, Cardiff University</api:line><api:line type="street-address">Museum Avenue</api:line><api:line type="city">Cardiff CF10 3AX</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>chris.wells@nanotether.co.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202578249</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>J-P</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital</api:line><api:line type="street-address">600 University Avenue</api:line><api:line type="city">Toronto, ON M5G 1X5</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:email-address>lambert@lunenfeld.ca</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">35248374900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Strain-Damerell</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>claire.strain-damerell@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">26641520800</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>nicola.burgess-brown@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">23479262400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>A-C</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital</api:line><api:line type="street-address">600 University Avenue</api:line><api:line type="city">Toronto, ON M5G 1X5</api:line><api:line type="country">can</api:line></api:address><api:address iso-country-code="CA"><api:line type="organisation">Department of Molecular Genetics, University of Toronto</api:line><api:line type="city">Toronto, ON M5S 1A8</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:email-address>gingras@lunenfeld.ca</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7003712519</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>susanne.muller-knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1186/1756-8935-7-14</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1186/1756-8935-7-14"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1186/1756-8935-7-14"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1756-8935</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1756-8935"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Epigenetics and Chromatin</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Bromodomain</api:keyword><api:keyword>Cell-based assay</api:keyword><api:keyword>Confocal microscopy</api:keyword><api:keyword>Epigenetics</api:keyword><api:keyword>Fluorescence recovery after photobleaching</api:keyword><api:keyword>Histone acetylation</api:keyword><api:keyword>Small-molecule inhibitor</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>7</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>BioMed Central Ltd.</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>7</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1756-8935" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1756-8935"><api:records><api:record source-name="era2012"><api:title>Epigenetics and Chromatin</api:title></api:record><api:record source-name="snip"><api:title>Epigenetics and Chromatin</api:title></api:record><api:record source-name="era2010"><api:title>Epigenetics and Chromatin</api:title></api:record><api:record source-name="sjr"><api:title>Epigenetics and Chromatin</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Epigenetics and Chromatin</api:title></api:record><api:record source-name="doaj"><api:title>Epigenetics &amp; Chromatin</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/478300/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/680100</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-06-30T09:37:55.317+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/680100"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/470972"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/470972">Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.</a></p></div></content><api:relationship id="680100" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/680100"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="470972" last-modified-when="2014-10-16T08:22:49.28+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/470972" created-when="2014-06-27T19:41:05.263+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-06-19</api:reporting-date-1><api:records><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24946055" is-preferred-record="true"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-molecule inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking. Here, we describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles. Our starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations. The selectivity of the lead compound against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members. To address the BET selectivity issue, X-ray crystal structures of the lead compound bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compounds. The crystal structures obtained revealed two distinct binding modes. By varying the aryl substitution pattern and developing conformationally constrained analogues, selectivity for CBP over BRD4(1) was increased. The optimized compound is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1). Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay. The optimized compounds are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biological roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Chemistry, University of Oxford , South Parks Road, Oxford OX1 3TA, U.K.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Singleton</api:last-name><api:initials>DC</api:initials></api:person><api:person><api:last-name>Tallant</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0002-5148-117X</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rooney</api:last-name><api:initials>TP</api:initials></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="514" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/514"/></api:links><api:last-name>Schofield</api:last-name><api:initials>CJ</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/ja412434f</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/ja412434f"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/ja412434f"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-5126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-5126"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24946055</api:identifier><api:identifier scheme="pmc">PMC4183655</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0002-7863</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0002-7863"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>26</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of the American Chemical Society</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9308</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>7</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field><api:files><api:file proprietary-id="http://europepmc.org/articles/PMC4183655?pdf=render"><api:file-url>http://europepmc.org/articles/PMC4183655?pdf=render</api:file-url><api:extension>pdf</api:extension></api:file></api:files></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24946055"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-molecule inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking. Here, we describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles. Our starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations. The selectivity of the lead compound against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members. To address the BET selectivity issue, X-ray crystal structures of the lead compound bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compounds. The crystal structures obtained revealed two distinct binding modes. By varying the aryl substitution pattern and developing conformationally constrained analogues, selectivity for CBP over BRD4(1) was increased. The optimized compound is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1). Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay. The optimized compounds are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biological roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Chemistry, University of Oxford , South Parks Road, Oxford OX1 3TA, U.K.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Singleton</api:last-name><api:initials>DC</api:initials></api:person><api:person><api:last-name>Tallant</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials></api:person><api:person><api:last-name>Rooney</api:last-name><api:initials>TP</api:initials></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="514" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/514"/></api:links><api:last-name>Schofield</api:last-name><api:initials>CJ</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24946055</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/ja412434f</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/ja412434f"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/ja412434f"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-5126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-5126"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC4183655</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>26</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Am Chem Soc</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9308</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>7</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000338692700017"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Singleton</api:last-name><api:initials>DC</api:initials></api:person><api:person><api:last-name>Tallant</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials></api:person><api:person><api:last-name>Rooney</api:last-name><api:initials>TPC</api:initials></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="514" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/514"/></api:links><api:last-name>Schofield</api:last-name><api:initials>CJ</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000338692700017&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/ja412434f</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/ja412434f"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/ja412434f"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AK8QI</api:identifier><api:identifier scheme="pubmed">24946055</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0002-7863</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0002-7863"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>26</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF THE AMERICAN CHEMICAL SOCIETY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9308</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>7</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84903739739"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Small-molecule inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking. Here, we describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles. Our starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations. The selectivity of the lead compound against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members. To address the BET selectivity issue, X-ray crystal structures of the lead compound bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compounds. The crystal structures obtained revealed two distinct binding modes. By varying the aryl substitution pattern and developing conformationally constrained analogues, selectivity for CBP over BRD4(1) was increased. The optimized compound is highly potent (K d = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1). Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay. The optimized compounds are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biological roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets. Â© 2014 American Chemical Society.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, University of Oxford</api:line><api:line type="street-address">South Parks Road</api:line><api:line type="city">Oxford OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">25642382900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55541113900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Singleton</api:last-name><api:initials>DC</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35739198000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Tallant</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">14036657300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202578249</api:identifier></api:identifiers></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56017594000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56198186100</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, University of Oxford</api:line><api:line type="street-address">South Parks Road</api:line><api:line type="city">Oxford OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7101690804</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rooney</api:last-name><api:initials>TPC</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, University of Oxford</api:line><api:line type="street-address">South Parks Road</api:line><api:line type="city">Oxford OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55501824100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6506165500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55790772400</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Worldwide Medicinal Chemistry</api:line><api:line type="street-address">Pfizer</api:line><api:line type="city">Cambridge, MA 02139</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603710592</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="514" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/514"/></api:links><api:last-name>Schofield</api:last-name><api:initials>CJ</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, University of Oxford</api:line><api:line type="street-address">South Parks Road</api:line><api:line type="city">Oxford OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35461437200</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute, University of Oxford, NDM Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>paul.brennan@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7402304490</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/ja412434f</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/ja412434f"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/ja412434f"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-5126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-5126"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0002-7863</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0002-7863"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>26</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of the American Chemical Society</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9308</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>7</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>American Chemical Society</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0002-7863" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0002-7863"><api:records><api:record source-name="era2012"><api:title>Journal of the American Chemical Society</api:title></api:record><api:record source-name="snip"><api:title>Journal of the American Chemical Society</api:title></api:record><api:record source-name="era2010"><api:title>Journal of the American Chemical Society</api:title></api:record><api:record source-name="science-metrix"><api:title>Journal of the American Chemical Society</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Journal of the American Chemical Society</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/470972/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/669509</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-06-16T14:19:12.86+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/669509"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464925"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-Ï interaction.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464925">A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-Ï interaction.</a></p></div></content><api:relationship id="669509" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/669509"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="464925" last-modified-when="2014-10-23T21:18:59.81+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464925" created-when="2014-05-15T00:07:35.22+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-05-12</api:reporting-date-1><api:records><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24821300" is-preferred-record="true"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands. While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors of a bromodomain outside the BET family. Structural and computational studies reveal that an internal hydrogen bond stabilizes the protein-bound conformation of the dihydroquinoxalinone series. The side chain of this series binds in an induced-fit pocket forming a cation-Ï interaction with R1173 of CREBBP. The most potent compound inhibits binding of CREBBP to chromatin in U2OS cells.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA (UK) http://conway.chem.ox.ac.uk/</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rooney</api:last-name><api:initials>TP</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Cortopassi</api:last-name><api:initials>WA</api:initials></api:person><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1160" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1160"/></api:links><api:last-name>Thompson</api:last-name><api:initials>AL</api:initials></api:person><api:person><api:last-name>Heightman</api:last-name><api:initials>TD</api:initials></api:person><api:person><api:last-name>Pryde</api:last-name><api:initials>DC</api:initials></api:person><api:person><api:last-name>Cook</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1171" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1171"/></api:links><api:last-name>Paton</api:last-name><api:initials>RS</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0002-5148-117X</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1002/anie.201402750</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1002/anie.201402750"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1002/anie.201402750"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1521-3773</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1521-3773"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24821300</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1433-7851</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1433-7851"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>24</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Angewandte Chemie (International ed. in English)</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>6126</api:begin-page><api:end-page>6130</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-Ï interaction.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24821300"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands. While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors of a bromodomain outside the BET family. Structural and computational studies reveal that an internal hydrogen bond stabilizes the protein-bound conformation of the dihydroquinoxalinone series. The side chain of this series binds in an induced-fit pocket forming a cation-Ï interaction with R1173 of CREBBP. The most potent compound inhibits binding of CREBBP to chromatin in U2OS cells.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rooney</api:last-name><api:initials>TP</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Mansfield Road, Oxford, OX1 3TA (UK) http://conway.chem.ox.ac.uk/</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Cortopassi</api:last-name><api:initials>WA</api:initials></api:person><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1160" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1160"/></api:links><api:last-name>Thompson</api:last-name><api:initials>AL</api:initials></api:person><api:person><api:last-name>Heightman</api:last-name><api:initials>TD</api:initials></api:person><api:person><api:last-name>Pryde</api:last-name><api:initials>DC</api:initials></api:person><api:person><api:last-name>Cook</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1171" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1171"/></api:links><api:last-name>Paton</api:last-name><api:initials>RS</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24821300</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1002/anie.201402750</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1002/anie.201402750"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1002/anie.201402750"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1521-3773</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1521-3773"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>24</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Angew Chem Int Ed Engl</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>CREBBP</api:keyword><api:keyword>bromodomain</api:keyword><api:keyword>enzyme inhibitors</api:keyword><api:keyword>epigenetics</api:keyword><api:keyword>ligand discovery</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Germany</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>6126</api:begin-page><api:end-page>6130</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>10</api:day><api:month>6</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-Ï interaction.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000337095000015"><api:citation-count>1</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rooney</api:last-name><api:initials>TPC</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Cortopassi</api:last-name><api:initials>WA</api:initials></api:person><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1160" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1160"/></api:links><api:last-name>Thompson</api:last-name><api:initials>AL</api:initials></api:person><api:person><api:last-name>Heightman</api:last-name><api:initials>TD</api:initials></api:person><api:person><api:last-name>Pryde</api:last-name><api:initials>DC</api:initials></api:person><api:person><api:last-name>Cook</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1171" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1171"/></api:links><api:last-name>Paton</api:last-name><api:initials>RS</api:initials><api:identifiers><api:identifier scheme="researcherid">A-4564-2010</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000337095000015&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1002/anie.201402750</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1002/anie.201402750"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1002/anie.201402750"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AI7RX</api:identifier><api:identifier scheme="pubmed">24821300</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1433-7851</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1433-7851"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>24</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>ANGEWANDTE CHEMIE-INTERNATIONAL EDITION</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>bromodomain</api:keyword><api:keyword>CREBBP</api:keyword><api:keyword>enzyme inhibitors</api:keyword><api:keyword>epigenetics</api:keyword><api:keyword>ligand discovery</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>6126</api:begin-page><api:end-page>6130</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-pi Interaction</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84902096046"><api:citation-count>1</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands. While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors of a bromodomain outside the BET family. Structural and computational studies reveal that an internal hydrogen bond stabilizes the protein-bound conformation of the dihydroquinoxalinone series. The side chain of this series binds in an induced-fit pocket forming a cation-Ï interaction with R1173 of CREBBP. The most potent compound inhibits binding of CREBBP to chromatin in U2OS cells. Â© 2014 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Rooney</api:last-name><api:initials>TPC</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, Chemistry Research Laboratory, University of Oxford</api:line><api:line type="street-address">Mansfield Road</api:line><api:line type="city">Oxford, OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55501824100</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Cortopassi</api:last-name><api:initials>WA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, Chemistry Research Laboratory, University of Oxford</api:line><api:line type="street-address">Mansfield Road</api:line><api:line type="city">Oxford, OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37015316800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Hay</api:last-name><api:initials>DA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">25642382900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55541113900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Tumber</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6506165500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rogers</api:last-name><api:initials>CM</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56198186100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56199070500</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1160" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1160"/></api:links><api:last-name>Thompson</api:last-name><api:initials>AL</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, Chemistry Research Laboratory, University of Oxford</api:line><api:line type="street-address">Mansfield Road</api:line><api:line type="city">Oxford, OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7404597548</api:identifier></api:identifiers></api:person><api:person><api:last-name>Heightman</api:last-name><api:initials>TD</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">TDH: Astex Pharmaceuticals</api:line><api:line type="street-address">436 Cambridge Science Park</api:line><api:line type="city">Cambridge, CB4 0QA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603468189</api:identifier></api:identifiers></api:person><api:person><api:last-name>Pryde</api:last-name><api:initials>DC</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Neusentis, Portway Building</api:line><api:line type="street-address">Granta Park</api:line><api:line type="city">Great Abington, Cambridge, CB21 6GS</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">14013801300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Cook</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Neusentis, Portway Building</api:line><api:line type="street-address">Granta Park</api:line><api:line type="city">Great Abington, Cambridge, CB21 6GS</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">EnVivo Pharmaceuticals</api:line><api:line type="street-address">500 Arsenal Street</api:line><api:line type="city">Watertown, MA 02472</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15065042000</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1171" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1171"/></api:links><api:last-name>Paton</api:last-name><api:initials>RS</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, Chemistry Research Laboratory, University of Oxford</api:line><api:line type="street-address">Mansfield Road</api:line><api:line type="city">Oxford, OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">14631098900</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7402304490</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="476" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/476"/></api:links><api:last-name>Conway</api:last-name><api:initials>SJ</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Chemistry, Chemistry Research Laboratory, University of Oxford</api:line><api:line type="street-address">Mansfield Road</api:line><api:line type="city">Oxford, OX1 3TA</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stuart.conway@chem.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7101690804</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1002/anie.201402750</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1002/anie.201402750"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1002/anie.201402750"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1521-3773</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1521-3773"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1433-7851</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1433-7851"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>24</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Angewandte Chemie - International Edition</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>bromodomain</api:keyword><api:keyword>CREBBP</api:keyword><api:keyword>enzyme inhibitors</api:keyword><api:keyword>epigenetics</api:keyword><api:keyword>ligand discovery</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>6126</api:begin-page><api:end-page>6130</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>10</api:day><api:month>6</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley-VCH Verlag</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A series of potent crebbp bromodomain ligands reveals an induced-fit pocket stabilized by a cation-Ï interaction</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>53</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1433-7851" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1433-7851"><api:records><api:record source-name="era2012"><api:title>Angewandte Chemie International Edition</api:title></api:record><api:record source-name="snip"><api:title>Angewandte Chemie - International Edition</api:title></api:record><api:record source-name="era2010"><api:title>Angewandte Chemie (International Edition)</api:title></api:record><api:record source-name="science-metrix"><api:title>Angewandte Chemie International Edition</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Angewandte Chemie International Edition</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464925/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/668788</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-05-13T14:11:59.327+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/668788"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464893"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464893">HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases.</a></p></div></content><api:relationship id="668788" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/668788"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="464893" last-modified-when="2014-05-13T14:11:59.457+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464893" created-when="2014-05-13T14:11:59.04+01:00" type-id="6" type="patent"><!--Publication type 6 is "patent"--><api:ever-approved>true</api:ever-approved><api:records><api:record format="native" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="5BA4ABF5-04D0-4FF5-84E1-100AB369A074" is-preferred-record="true"><api:verification-status>unverified</api:verification-status><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Bianchi</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>Bonaldi</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Scaffidi</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Degryse</api:last-name><api:initials>B</api:initials></api:person></api:people></api:field><api:field name="patent-number" type="text" display-name="Patent number"><api:text>WO 02/074337</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases.</api:text></api:field></api:native></api:record></api:records><api:fields/><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/464893/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/668397</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-06-16T14:19:20.34+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/668397"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/462551"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/462551">Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.</a></p></div></content><api:relationship id="668397" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/668397"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="462551" last-modified-when="2014-08-07T04:30:42.49+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/462551" created-when="2014-04-23T19:55:22.09+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-03-30</api:reporting-date-1><api:records><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24497639" is-preferred-record="true"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family. It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the positive transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation. An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies. We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail. We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding. We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochemical and biophysical methods. The impact of these mutations was confirmed in a cellular environment. Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1. Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible. Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacological properties.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="DE"><api:line type="full">From the Global Drug Discovery, Bayer HealthCare, 13353 Berlin, Germany.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Jung</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schulze</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Badock</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>EberspÃ¤cher</api:last-name><api:initials>U</api:initials></api:person><api:person><api:last-name>Moosmayer</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Bader</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Schmees</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>FernÃ¡ndez-MontalvÃ¡n</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Haendler</api:last-name><api:initials>B</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.m113.523019</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1074/jbc.m113.523019"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.m113.523019"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1083-351X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1083-351X"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24497639</api:identifier><api:identifier scheme="pmc">PMC3979416</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0021-9258"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Journal of biological chemistry</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Chromatin</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Azepines</api:keyword><api:keyword scheme="mesh">Triazoles</api:keyword><api:keyword scheme="mesh">Peptide Fragments</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Histones</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Ligands</api:keyword><api:keyword scheme="mesh">Mutagenesis, Site-Directed</api:keyword><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Protein Binding</api:keyword><api:keyword scheme="mesh">Acetylation</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Molecular Sequence Data</api:keyword><api:keyword scheme="mesh">Protein Stability</api:keyword><api:keyword scheme="mesh">HEK293 Cells</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9304</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>289</api:text></api:field></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24497639"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family. It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the positive transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation. An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies. We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail. We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding. We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochemical and biophysical methods. The impact of these mutations was confirmed in a cellular environment. Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1. Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible. Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacological properties.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Jung</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="full">From the Global Drug Discovery, Bayer HealthCare, 13353 Berlin, Germany.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schulze</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Badock</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>EberspÃ¤cher</api:last-name><api:initials>U</api:initials></api:person><api:person><api:last-name>Moosmayer</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Bader</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Schmees</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>FernÃ¡ndez-MontalvÃ¡n</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Haendler</api:last-name><api:initials>B</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24497639</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M113.523019</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1074/jbc.M113.523019"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M113.523019"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1083-351X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1083-351X"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3979416</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Biol Chem</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Acetylation</api:keyword><api:keyword>Anticancer Drug</api:keyword><api:keyword>BET Family</api:keyword><api:keyword>BRD4</api:keyword><api:keyword>Bromodomain</api:keyword><api:keyword>Cancer Therapy</api:keyword><api:keyword>Chromatin</api:keyword><api:keyword>Histones</api:keyword><api:keyword>Mutant</api:keyword><api:keyword scheme="mesh">Acetylation</api:keyword><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Azepines</api:keyword><api:keyword scheme="mesh">Chromatin</api:keyword><api:keyword scheme="mesh">HEK293 Cells</api:keyword><api:keyword scheme="mesh">Histones</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Ligands</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Molecular Sequence Data</api:keyword><api:keyword scheme="mesh">Mutagenesis, Site-Directed</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Peptide Fragments</api:keyword><api:keyword scheme="mesh">Protein Binding</api:keyword><api:keyword scheme="mesh">Protein Stability</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Triazoles</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9304</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>M113.523019</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>28</api:day><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>289</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000333472100047"><api:citation-count>1</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Jung</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schulze</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Badock</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>Eberspaecher</api:last-name><api:initials>U</api:initials></api:person><api:person><api:last-name>Moosmayer</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Bader</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Schmees</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Fernandez-Montalvan</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Haendler</api:last-name><api:initials>B</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000333472100047&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M113.523019</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1074/jbc.M113.523019"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M113.523019"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AD7UJ</api:identifier><api:identifier scheme="pubmed">24497639</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0021-9258"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF BIOLOGICAL CHEMISTRY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Anticancer Drug</api:keyword><api:keyword>Cancer Therapy</api:keyword><api:keyword>Chromatin</api:keyword><api:keyword>Histones</api:keyword><api:keyword>Mutant</api:keyword><api:keyword>Acetylation</api:keyword><api:keyword>BET Family</api:keyword><api:keyword>BRD4</api:keyword><api:keyword>Bromodomain</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9304</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>28</api:day><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Affinity Map of Bromodomain Protein 4 ( BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>289</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84897448118"><api:citation-count>1</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family. It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the positive transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation. An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies. We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail. We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding. We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochemical and biophysical methods. The impact of these mutations was confirmed in a cellular environment. Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1. Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible. Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacological properties. Â© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Jung</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address><api:address iso-country-code="DE"><api:line type="organisation">Institute of Chemistry and Biochemistry, Free University</api:line><api:line type="city">14195 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56094401200</api:identifier></api:identifiers></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Schulze</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56095156900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Badock</api:last-name><api:initials>V</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603192605</api:identifier></api:identifiers></api:person><api:person><api:last-name>EberspÃ¤cher</api:last-name><api:initials>U</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6507340690</api:identifier></api:identifiers></api:person><api:person><api:last-name>Moosmayer</api:last-name><api:initials>D</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603899311</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bader</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005820559</api:identifier></api:identifiers></api:person><api:person><api:last-name>Schmees</api:last-name><api:initials>N</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7801573639</api:identifier></api:identifiers></api:person><api:person><api:last-name>FernÃ¡ndez-MontalvÃ¡n</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6507513902</api:identifier></api:identifiers></api:person><api:person><api:last-name>Haendler</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Global Drug Discovery, Bayer HealthCare</api:line><api:line type="city">13353 Berlin</api:line><api:line type="country">deu</api:line></api:address><api:address iso-country-code="DE"><api:line type="organisation">Dept. of Chromatin Modulation and OncoGenomics, Therapeutic Research Group Oncology/Gynecological Therapies, Bayer HealthCare</api:line><api:line type="street-address">MÃ¼llerstr. 178</api:line><api:line type="city">D-13353 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:email-address>bernard.haendler@bayer.com</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7004462472</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M113.523019</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1074/jbc.M113.523019"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M113.523019"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1083-351X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1083-351X"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0021-9258"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9304</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>30</api:day><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>American Society for Biochemistry and Molecular Biology Inc.</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>289</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1074/jbc.M113.523019"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Jung</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schulze</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Badock</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>Eberspacher</api:last-name><api:initials>U</api:initials></api:person><api:person><api:last-name>Moosmayer</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Bader</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Schmees</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Fernandez-Montalvan</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Haendler</api:last-name><api:initials>B</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1074/jbc.M113.523019</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1074/jbc.M113.523019"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1074/jbc.M113.523019"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1083-351X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1083-351X"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0021-9258</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0021-9258"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>13</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Biological Chemistry</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>9304</api:begin-page><api:end-page>9319</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>28</api:day><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Affinity Map of Bromodomain Protein 4 (BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>289</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0021-9258" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0021-9258"><api:records><api:record source-name="era2012"><api:title>Journal of Biological Chemistry</api:title></api:record><api:record source-name="snip"><api:title>Journal of Biological Chemistry</api:title></api:record><api:record source-name="era2010"><api:title>Journal of Biological Chemistry</api:title></api:record><api:record source-name="science-metrix"><api:title>The Journal of biological chemistry</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Journal of Biological Chemistry</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/462551/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/664866</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-06-16T14:19:30.247+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/664866"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/457780"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Discovery of BET bromodomain inhibitors and their role in target validation</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/457780">Discovery of BET bromodomain inhibitors and their role in target validation</a></p></div></content><api:relationship id="664866" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/664866"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="457780" last-modified-when="2014-08-03T15:16:40.073+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/457780" created-when="2014-03-22T16:37:19.383+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-03-01</api:reporting-date-1><api:records><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000333227000006" is-preferred-record="true"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000333227000006&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1039/c3md00291h</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1039/c3md00291h"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1039/c3md00291h"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AD4NE</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>2040-2503</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-2503"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>MEDCHEMCOMM</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>288</api:begin-page><api:end-page>296</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Discovery of BET bromodomain inhibitors and their role in target validation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84895114818"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains (BRDs) are protein interaction modules that selectively recognize Îµ-N-acetylated lysine residues. BRDs are present in diverse proteins that play key functions in chromatin organization and regulation of gene transcription. Aberrant transcription is a hallmark of many diseases in particular cancer and inflammation. The complexity of molecular processes regulating gene transcription identified transcriptional regulators as interesting targets for the development of specific chemical tool molecules (chemical probes) that help to understand the molecular mechanisms of transcription and to explore the potential of BRD mediated interactions as sites for pharmaceutical intervention. Recently a number of highly specific inhibitors have been developed against the BET (bromo and extra terminal) family of bromodomains. The availability of selective BRD inhibitors had a significant impact on the validation of bromodomain-containing proteins as targets for drug development and for our understanding of the biological roles of these proteins. In this review we will summarize the discovery of BET bromodomain inhibitors and their roles in target validation. Â© 2014 The Royal Society of Chemistry.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1039/c3md00291h</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1039/c3md00291h"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1039/c3md00291h"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>2040-2511</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-2511"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>2040-2503</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-2503"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>MedChemComm</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>288</api:begin-page><api:end-page>296</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Royal Society of Chemistry</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Discovery of BET bromodomain inhibitors and their role in target validation</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1039/c3md00291h"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1039/c3md00291h</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1039/c3md00291h"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1039/c3md00291h"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>2040-2511</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-2511"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>2040-2503</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-2503"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>MedChemComm</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>288</api:begin-page><api:end-page>288</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Discovery of BET bromodomain inhibitors and their role in target validation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="2040-2503" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-2503"><api:records><api:record source-name="era2012"><api:title>MedChemComm</api:title></api:record><api:record source-name="snip"><api:title>MedChemComm</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>MedChemComm</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/457780/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/660523</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-06-16T14:19:34.047+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/660523"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/446725"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/446725">Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.</a></p></div></content><api:relationship id="660523" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/660523"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="446725" last-modified-when="2014-10-31T05:10:25.607+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/446725" created-when="2014-01-25T06:49:18.58+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-01-17</api:reporting-date-1><api:records><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24438162" is-preferred-record="true"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>GAK (cyclin G-associated kinase) is a key regulator of clathrin-coated vesicle trafficking and plays a central role during development. Additionally, due to the unusually high plasticity of its catalytic domain, it is a frequent 'off-target' of clinical kinase inhibitors associated with respiratory side effects of these drugs. In the present paper, we determined the crystal structure of the GAK catalytic domain alone and in complex with specific single-chain antibodies (nanobodies). GAK is constitutively active and weakly associates in solution. The GAK apo structure revealed a dimeric inactive state of the catalytic domain mediated by an unusual activation segment interaction. Co-crystallization with the nanobody NbGAK_4 trapped GAK in a dimeric arrangement similar to the one observed in the apo structure, whereas NbGAK_1 captured the activation segment of monomeric GAK in a well-ordered conformation, representing features of the active kinase. The presented structural and biochemical data provide insight into the domain plasticity of GAK and demonstrate the utility of nanobodies to gain insight into conformational changes of dynamic molecules. In addition, we present structural data on the binding mode of ATP mimetic inhibitors and enzyme kinetic data, which will support rational inhibitor design of inhibitors to reduce the off-target effect on GAK.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">*University of Oxford, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Chaikuad</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Vincke</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Kaufholz</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Zenn</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Zimmermann</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>GutiÃ©rrez</api:last-name><api:initials>C</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0003-0764-7408</api:identifier></api:identifiers></api:person><api:person><api:last-name>Zhang</api:last-name><api:initials>RG</api:initials></api:person><api:person><api:last-name>Hatzos-Skintges</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Joachimiak</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Muyldermans</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Herberg</api:last-name><api:initials>FW</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1042/bj20131399</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1042/bj20131399"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1042/bj20131399"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1470-8728</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1470-8728"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24438162</api:identifier><api:identifier scheme="pmc">PMC3957475</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-6021</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0264-6021"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>The Biochemical journal</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Camels</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Protein-Serine-Threonine Kinases</api:keyword><api:keyword scheme="mesh">Intracellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh">Apoproteins</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">Catalytic Domain</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Protein Multimerization</api:keyword><api:keyword scheme="mesh">Single-Domain Antibodies</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>59</api:begin-page><api:end-page>69</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>459</api:text></api:field><api:files><api:file proprietary-id="http://europepmc.org/articles/PMC3957475?pdf=render"><api:file-url>http://europepmc.org/articles/PMC3957475?pdf=render</api:file-url><api:extension>pdf</api:extension></api:file></api:files></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24438162"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>GAK (cyclin G-associated kinase) is a key regulator of clathrin-coated vesicle trafficking and plays a central role during development. Additionally, due to the unusually high plasticity of its catalytic domain, it is a frequent 'off-target' of clinical kinase inhibitors associated with respiratory side effects of these drugs. In the present paper, we determined the crystal structure of the GAK catalytic domain alone and in complex with specific single-chain antibodies (nanobodies). GAK is constitutively active and weakly associates in solution. The GAK apo structure revealed a dimeric inactive state of the catalytic domain mediated by an unusual activation segment interaction. Co-crystallization with the nanobody NbGAK_4 trapped GAK in a dimeric arrangement similar to the one observed in the apo structure, whereas NbGAK_1 captured the activation segment of monomeric GAK in a well-ordered conformation, representing features of the active kinase. The presented structural and biochemical data provide insight into the domain plasticity of GAK and demonstrate the utility of nanobodies to gain insight into conformational changes of dynamic molecules. In addition, we present structural data on the binding mode of ATP mimetic inhibitors and enzyme kinetic data, which will support rational inhibitor design of inhibitors to reduce the off-target effect on GAK.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Chaikuad</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">*University of Oxford, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">*University of Oxford, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Vincke</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="BE"><api:line type="full">â Research Unit of Cellular and Molecular Immunology and Department of Structural Biology, VIB, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Kaufholz</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="full">â¡Department of Biochemistry, University of Kassel, Heinrich-Plett Strasse 40, 34132 Kassel, Germany.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Zenn</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="full">Â§Biaffin GmbH &amp; CoKG, Heinrich-Plett Strasse 40, 34132 Kassel, Germany.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Zimmermann</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="full">Â§Biaffin GmbH &amp; CoKG, Heinrich-Plett Strasse 40, 34132 Kassel, Germany.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>GutiÃ©rrez</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="ES"><api:line type="full">Â¶Department of Animal Medicine and Surgery, Veterinary Faculty, University of Las Palmas de Gran Canaria, 35416, Arucas, Las Palmas, Spain.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Zhang</api:last-name><api:initials>RG</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">â¥Midwest Center for Structural Genomics and Structural Biology Center, Biosciences Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439, U.S.A.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Hatzos-Skintges</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">â¥Midwest Center for Structural Genomics and Structural Biology Center, Biosciences Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439, U.S.A.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Joachimiak</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">â¥Midwest Center for Structural Genomics and Structural Biology Center, Biosciences Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439, U.S.A.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Muyldermans</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="BE"><api:line type="full">â Research Unit of Cellular and Molecular Immunology and Department of Structural Biology, VIB, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Herberg</api:last-name><api:initials>FW</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">*University of Oxford, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">*University of Oxford, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Old Road Campus Research Building, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24438162</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1042/BJ20131399</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1042/BJ20131399"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1042/BJ20131399"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1470-8728</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1470-8728"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3957475</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Biochem J</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Apoproteins</api:keyword><api:keyword scheme="mesh">Camels</api:keyword><api:keyword scheme="mesh">Catalytic Domain</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Intracellular Signaling Peptides and Proteins</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Protein Multimerization</api:keyword><api:keyword scheme="mesh">Protein-Serine-Threonine Kinases</api:keyword><api:keyword scheme="mesh">Single-Domain Antibodies</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>59</api:begin-page><api:end-page>69</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>BJ20131399</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>459</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000333718700006"><api:citation-count>1</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Chaikuad</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Vincke</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Kaufholz</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Zenn</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Zimmermann</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Gutierrez</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Zhang</api:last-name><api:initials>R-G</api:initials></api:person><api:person><api:last-name>Hatzos-Skintges</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Joachimiak</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Muyldermans</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Herberg</api:last-name><api:initials>FW</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000333718700006&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1042/BJ20131399</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1042/BJ20131399"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1042/BJ20131399"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AE1GV</api:identifier><api:identifier scheme="pubmed">24438162</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-6021</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0264-6021"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BIOCHEMICAL JOURNAL</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>activation loop</api:keyword><api:keyword>cyclin G-associated kinase</api:keyword><api:keyword>drug side effect</api:keyword><api:keyword>kinase inhibitor</api:keyword><api:keyword>nanobody</api:keyword><api:keyword>protein structure</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>59</api:begin-page><api:end-page>69</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>459</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84896138811"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>GAK (cyclin G-associated kinase) is a key regulator of clathrin-coated vesicle trafficking and plays a central role during development. Additionally, due to the unusually high plasticity of its catalytic domain, it is a frequent 'off-target' of clinical kinase inhibitors associated with respiratory side effects of these drugs. In the present paper, we determined the crystal structure of the GAK catalytic domain alone and in complex with specific single-chain antibodies (nanobodies). GAK is constitutively active and weakly associates in solution. The GAK apo structure revealed a dimeric inactive state of the catalytic domain mediated by an unusual activation segment interaction. Co-crystallization with the nanobody NbGAK-4 trapped GAK in a dimeric arrangement similar to the one observed in the apo structure, whereas NbGAK-1 captured the activation segment of monomeric GAK in a well-ordered conformation, representing features of the active kinase. The presented structural and biochemical data provide insight into the domain plasticity of GAK and demonstrate the utility of nanobodies to gain insight into conformational changes of dynamic molecules. In addition, we present structural data on the binding mode of ATP mimetic inhibitors and enzyme kinetic data, which will support rational inhibitor design of inhibitors to reduce the off-target effect on GAK. Â© 2014 The Author(s).</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Chaikuad</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford, Target Discovery Institute (TDI), Structural Genomics Consortium (SGC)</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9941747800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford, Target Discovery Institute (TDI), Structural Genomics Consortium (SGC)</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">50262281800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Vincke</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Research Unit of Cellular and Molecular Immunology, Department of Structural Biology, Vrije Universiteit Brussel</api:line><api:line type="street-address">Pleinlaan 2</api:line><api:line type="city">1050 Brussels</api:line><api:line type="country">bel</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">8622097100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kaufholz</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Department of Biochemistry, University of Kassel</api:line><api:line type="street-address">Heinrich-Plett Strasse 40</api:line><api:line type="city">34132 Kassel</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36615462900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Zenn</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Biaffin GmbH and CoKG</api:line><api:line type="street-address">Heinrich-Plett Strasse 40</api:line><api:line type="city">34132 Kassel</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603722712</api:identifier></api:identifiers></api:person><api:person><api:last-name>Zimmermann</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Biaffin GmbH and CoKG</api:line><api:line type="street-address">Heinrich-Plett Strasse 40</api:line><api:line type="city">34132 Kassel</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7103160083</api:identifier></api:identifiers></api:person><api:person><api:last-name>GutiÃ©rrez</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="ES"><api:line type="organisation">Department of Animal Medicine and Surgery, Veterinary Faculty, University of Las Palmas de Gran Canaria</api:line><api:line type="city">35416, Arucas, Las Palmas</api:line><api:line type="country">esp</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55802371743</api:identifier></api:identifiers></api:person><api:person><api:last-name>Zhang</api:last-name><api:initials>R-G</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Midwest Center for Structural Genomics and Structural Biology Center, Biosciences Division, Argonne National Laboratory</api:line><api:line type="street-address">9700 South Cass Avenue</api:line><api:line type="city">Argonne, IL 60439</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7404864581</api:identifier></api:identifiers></api:person><api:person><api:last-name>Hatzos-Skintges</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Midwest Center for Structural Genomics and Structural Biology Center, Biosciences Division, Argonne National Laboratory</api:line><api:line type="street-address">9700 South Cass Avenue</api:line><api:line type="city">Argonne, IL 60439</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">50261885200</api:identifier></api:identifiers></api:person><api:person><api:last-name>Joachimiak</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Midwest Center for Structural Genomics and Structural Biology Center, Biosciences Division, Argonne National Laboratory</api:line><api:line type="street-address">9700 South Cass Avenue</api:line><api:line type="city">Argonne, IL 60439</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55409106600</api:identifier></api:identifiers></api:person><api:person><api:last-name>Muyldermans</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Research Unit of Cellular and Molecular Immunology, Department of Structural Biology, Vrije Universiteit Brussel</api:line><api:line type="street-address">Pleinlaan 2</api:line><api:line type="city">1050 Brussels</api:line><api:line type="country">bel</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005810441</api:identifier></api:identifiers></api:person><api:person><api:last-name>Herberg</api:last-name><api:initials>FW</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Department of Biochemistry, University of Kassel</api:line><api:line type="street-address">Heinrich-Plett Strasse 40</api:line><api:line type="city">34132 Kassel</api:line><api:line type="country">deu</api:line></api:address><api:address iso-country-code="DE"><api:line type="organisation">Biaffin GmbH and CoKG</api:line><api:line type="street-address">Heinrich-Plett Strasse 40</api:line><api:line type="city">34132 Kassel</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701341315</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford, Target Discovery Institute (TDI), Structural Genomics Consortium (SGC)</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford, Target Discovery Institute (TDI), Structural Genomics Consortium (SGC)</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>susanne.muller-knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1042/BJ20131399</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1042/BJ20131399"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1042/BJ20131399"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1470-8728</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1470-8728"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24438162</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-6021</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0264-6021"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Biochemical Journal</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Activation loop</api:keyword><api:keyword>Cyclin G-associated kinase</api:keyword><api:keyword>Drug side effect</api:keyword><api:keyword>Kinase inhibitor</api:keyword><api:keyword>Nanobody</api:keyword><api:keyword>Protein structure</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>59</api:begin-page><api:end-page>69</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Portland Press Ltd</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>459</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1042/BJ20131399"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Chaikuad</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Vincke</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Kaufholz</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Zenn</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Zimmermann</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>GutiÃ©rrez</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Zhang</api:last-name><api:initials>RG</api:initials></api:person><api:person><api:last-name>HatzosâSkintges</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Joachimiak</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Muyldermans</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Herberg</api:last-name><api:initials>FW</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1042/BJ20131399</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1042/BJ20131399"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1042/BJ20131399"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1470-8728</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1470-8728"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0264-6021</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0264-6021"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Biochemical Journal</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>59</api:begin-page><api:end-page>69</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>459</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0264-6021" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0264-6021"><api:records><api:record source-name="era2012"><api:title>Biochemical Journal</api:title></api:record><api:record source-name="snip"><api:title>Biochemical Journal</api:title></api:record><api:record source-name="era2010"><api:title>Biochemical Journal</api:title></api:record><api:record source-name="science-metrix"><api:title>The Biochemical journal</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Biochemical Journal</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/446725/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/647851</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-03-09T17:35:13.83+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/647851"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/450967"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/450967">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.</a></p></div></content><api:relationship id="647851" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/647851"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>true</api:is-favourite><api:related direction="from"><api:object category="publication" id="450967" last-modified-when="2014-11-10T03:32:40.45+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/450967" created-when="2014-03-07T14:49:20.12+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:merge-history><api:merge when="2014-05-15T09:57:21.1+01:00"><api:merged-object id="459087" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/459087"/><api:merged-into-object id="450967" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/450967"/></api:merge></api:merge-history><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2014-03-02</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24584101" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clinical responses to targeted therapies. The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clinical development challenges. Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy. Here we report that several clinical kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors. Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clinical PLK1 and JAK2-FLT3 kinase inhibitors, respectively, is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacological targeting. Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Ciceri</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">1] KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA. [2].</api:line></api:address></api:addresses></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK. [3].</api:line></api:address></api:addresses></api:person><api:person><api:last-name>O'Mahony</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">1] BioSeek Division of DiscoveRx Corporation, San Francisco, California, USA. [2].</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research (LICR), Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Hunt</api:last-name><api:initials>JP</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Lasater</api:last-name><api:initials>EA</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">Division of Hematology/Oncology, University of California-San Francisco, San Francisco, California, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Pallares</api:last-name><api:initials>G</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research (LICR), Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Wodicka</api:last-name><api:initials>LM</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Shah</api:last-name><api:initials>NP</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">Division of Hematology/Oncology, University of California-San Francisco, San Francisco, California, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Treiber</api:last-name><api:initials>DK</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">1] Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Oxford, UK. [2] Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), Oxford, UK.</api:line></api:address></api:addresses></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24584101</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.1471</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.1471"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.1471"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3998711</api:identifier><api:identifier scheme="nihms">NIHMS559591</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nat Chem Biol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">Calorimetry</api:keyword><api:keyword scheme="mesh">Cell Line, Tumor</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Drug Design</api:keyword><api:keyword scheme="mesh">Drug Interactions</api:keyword><api:keyword scheme="mesh">Drug Screening Assays, Antitumor</api:keyword><api:keyword scheme="mesh">Epigenesis, Genetic</api:keyword><api:keyword scheme="mesh">High-Throughput Screening Assays</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Neoplasms</api:keyword><api:keyword scheme="mesh">Polypharmacology</api:keyword><api:keyword scheme="mesh">Protein Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins c-myc</api:keyword><api:keyword scheme="mesh">Pteridines</api:keyword><api:keyword scheme="mesh">Pyrrolidines</api:keyword><api:keyword scheme="mesh">Recombinant Proteins</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Sulfonamides</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>305</api:begin-page><api:end-page>312</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>nchembio.1471</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, N.I.H., Extramural</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24584101"><api:citation-count>11</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clinical responses to targeted therapies. The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clinical development challenges. Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy. Here we report that several clinical kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors. Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clinical PLK1 and JAK2-FLT3 kinase inhibitors, respectively, is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacological targeting. Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="US"><api:line type="full">1] KINOMEscan Division of DiscoveRx Corporation, San Diego, California, USA. [2].</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Ciceri</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>O'Mahony</api:last-name><api:initials>A</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0001-8403-0351</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Hunt</api:last-name><api:initials>JP</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0002-8797-3977</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lasater</api:last-name><api:initials>EA</api:initials></api:person><api:person><api:last-name>Pallares</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wodicka</api:last-name><api:initials>LM</api:initials></api:person><api:person><api:last-name>Shah</api:last-name><api:initials>NP</api:initials></api:person><api:person><api:last-name>Treiber</api:last-name><api:initials>DK</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.1471</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.1471"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.1471"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24584101</api:identifier><api:identifier scheme="pmc">PMC3998711</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature chemical biology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cell Line, Tumor</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Neoplasms</api:keyword><api:keyword scheme="mesh">Sulfonamides</api:keyword><api:keyword scheme="mesh">Pyrrolidines</api:keyword><api:keyword scheme="mesh">Pteridines</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins c-myc</api:keyword><api:keyword scheme="mesh">Recombinant Proteins</api:keyword><api:keyword scheme="mesh">Antineoplastic Combined Chemotherapy Protocols</api:keyword><api:keyword scheme="mesh">Protein Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Blotting, Western</api:keyword><api:keyword scheme="mesh">Calorimetry</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Drug Screening Assays, Antitumor</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Epigenesis, Genetic</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Drug Design</api:keyword><api:keyword scheme="mesh">Drug Interactions</api:keyword><api:keyword scheme="mesh">High-Throughput Screening Assays</api:keyword><api:keyword scheme="mesh">Polypharmacology</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>305</api:begin-page><api:end-page>312</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Research Support, N.I.H., Extramural</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field><api:files><api:file proprietary-id="http://europepmc.org/articles/PMC3998711?pdf=render"><api:file-url>http://europepmc.org/articles/PMC3998711?pdf=render</api:file-url><api:extension>pdf</api:extension></api:file></api:files></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000333172900014"><api:citation-count>9</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Ciceri</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>O'Mahony</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Hunt</api:last-name><api:initials>JP</api:initials></api:person><api:person><api:last-name>Lasater</api:last-name><api:initials>EA</api:initials></api:person><api:person><api:last-name>Pallares</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wodicka</api:last-name><api:initials>LM</api:initials></api:person><api:person><api:last-name>Shah</api:last-name><api:initials>NP</api:initials></api:person><api:person><api:last-name>Treiber</api:last-name><api:initials>DK</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000333172900014&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.1471</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.1471"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.1471"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">AD3UY</api:identifier><api:identifier scheme="pubmed">24584101</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>NATURE CHEMICAL BIOLOGY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>305</api:begin-page><api:end-page>+</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84896611007"><api:citation-count>10</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clinical responses to targeted therapies. The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clinical development challenges. Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy. Here we report that several clinical kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors. Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clinical PLK1 and JAK2-FLT3 kinase inhibitors, respectively, is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacological targeting. Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors. Â© 2014 Nature America, Inc. All rights reserved.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Ciceri</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">KINOMEscan Division of DiscoveRx Corporation</api:line><api:line type="city">San Diego, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602177529</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:last-name>O'Mahony</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">BioSeek Division of DiscoveRx Corporation</api:line><api:line type="city">San Francisco, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003785027</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research (LICR)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Hunt</api:last-name><api:initials>JP</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">KINOMEscan Division of DiscoveRx Corporation</api:line><api:line type="city">San Diego, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55465300100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lasater</api:last-name><api:initials>EA</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Division of Hematology/Oncology, University of California-San Francisco</api:line><api:line type="city">San Francisco, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">24478622600</api:identifier></api:identifiers></api:person><api:person><api:last-name>Pallares</api:last-name><api:initials>G</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">KINOMEscan Division of DiscoveRx Corporation</api:line><api:line type="city">San Diego, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6507328839</api:identifier></api:identifiers></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Ludwig Institute for Cancer Research (LICR)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202578249</api:identifier></api:identifiers></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55541113900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wodicka</api:last-name><api:initials>LM</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">KINOMEscan Division of DiscoveRx Corporation</api:line><api:line type="city">San Diego, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602701798</api:identifier></api:identifiers></api:person><api:person><api:last-name>Shah</api:last-name><api:initials>NP</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Division of Hematology/Oncology, University of California-San Francisco</api:line><api:line type="city">San Francisco, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55543905400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Treiber</api:last-name><api:initials>DK</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">KINOMEscan Division of DiscoveRx Corporation</api:line><api:line type="city">San Diego, CA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:email-address>dtreiber@discoverx.com</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">6602095947</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI)</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.1471</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.1471"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.1471"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24584101</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature Chemical Biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>305</api:begin-page><api:end-page>312</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>NCHEMBIO1471</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2014</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Nature Publishing Group</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84894431955"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clinical responses to targeted therapies. The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clinical development challenges. Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy. Here we report that several clinical kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors. Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clinical PLK1 and JAK2-FLT3 kinase inhibitors, respectively, is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacological targeting. Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Ciceri</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>O'Mahony</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Hunt</api:last-name><api:initials>JP</api:initials></api:person><api:person><api:last-name>Pallares</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Wodicka</api:last-name><api:initials>LM</api:initials></api:person><api:person><api:last-name>Treiber</api:last-name><api:initials>DK</api:initials></api:person><api:person><api:last-name>Lasater</api:last-name><api:initials>EA</api:initials></api:person><api:person><api:last-name>Shah</api:last-name><api:initials>NP</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.1471</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.1471"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.1471"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature Chemical Biology</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1038/nchembio.1471"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Ciceri</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>O'Mahony</api:last-name><api:initials>A</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Hunt</api:last-name><api:initials>JP</api:initials></api:person><api:person><api:last-name>Lasater</api:last-name><api:initials>EA</api:initials></api:person><api:person><api:last-name>Pallares</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wodicka</api:last-name><api:initials>LM</api:initials></api:person><api:person><api:last-name>Shah</api:last-name><api:initials>NP</api:initials></api:person><api:person><api:last-name>Treiber</api:last-name><api:initials>DK</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.1471</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.1471"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.1471"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature Chemical Biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>305</api:begin-page><api:end-page>312</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>3</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1552-4450" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"><api:records><api:record source-name="era2012"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="snip"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="era2010"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="science-metrix"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Nature Chemical Biology</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/450967/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/638434</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-01-13T15:34:59.913+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/638434"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/441659"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/441659">[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.</a></p></div></content><api:relationship id="638434" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/638434"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="441659" last-modified-when="2014-10-16T12:56:43.32+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/441659" created-when="2013-12-13T13:21:32.957+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2013-12-08</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24313754" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains are gaining increasing interest as drug targets. Commercially sourced and de novo synthesized substituted [1,2,4]triazolo[4,3-a]phthalazines are potent inhibitors of both the BET bromodomains such as BRD4 as well as bromodomains outside the BET family such as BRD9, CECR2, and CREBBP. This new series of compounds is the first example of submicromolar inhibitors of bromodomains outside the BET subfamily. Representative compounds are active in cells exhibiting potent cellular inhibition activity in a FRAP model of CREBBP and chromatin association. The compounds described are valuable starting points for discovery of selective bromodomain inhibitors and inhibitors with mixed bromodomain pharmacology.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SJ</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>BD</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24313754</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/jm401568s</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/jm401568s"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/jm401568s"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-4804</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-4804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3906316</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Med Chem</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">CREB-Binding Protein</api:keyword><api:keyword scheme="mesh">Cell Line, Tumor</api:keyword><api:keyword scheme="mesh">Chromatin Assembly and Disassembly</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Molecular Docking Simulation</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Phthalazines</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Proteins</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Triazoles</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>462</api:begin-page><api:end-page>476</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>57</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24313754"><api:citation-count>5</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains are gaining increasing interest as drug targets. Commercially sourced and de novo synthesized substituted [1,2,4]triazolo[4,3-a]phthalazines are potent inhibitors of both the BET bromodomains such as BRD4 as well as bromodomains outside the BET family such as BRD9, CECR2, and CREBBP. This new series of compounds is the first example of submicromolar inhibitors of bromodomains outside the BET subfamily. Representative compounds are active in cells exhibiting potent cellular inhibition activity in a FRAP model of CREBBP and chromatin association. The compounds described are valuable starting points for discovery of selective bromodomain inhibitors and inhibitors with mixed bromodomain pharmacology.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford , Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, U.K.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SJ</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>BD</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/jm401568s</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/jm401568s"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/jm401568s"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-4804</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-4804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24313754</api:identifier><api:identifier scheme="pmc">PMC3906316</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-2623</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0022-2623"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of medicinal chemistry</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cell Line, Tumor</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Triazoles</api:keyword><api:keyword scheme="mesh">Phthalazines</api:keyword><api:keyword scheme="mesh">Proteins</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Chromatin Assembly and Disassembly</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">CREB-Binding Protein</api:keyword><api:keyword scheme="mesh">Molecular Docking Simulation</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>462</api:begin-page><api:end-page>476</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>1</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>57</api:text></api:field><api:files><api:file proprietary-id="http://europepmc.org/articles/PMC3906316?pdf=render"><api:file-url>http://europepmc.org/articles/PMC3906316?pdf=render</api:file-url><api:extension>pdf</api:extension></api:file></api:files></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000330252500016"><api:citation-count>5</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SJ</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>BD</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000330252500016&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/jm401568s</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/jm401568s"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/jm401568s"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">297JU</api:identifier><api:identifier scheme="pubmed">24313754</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-2623</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0022-2623"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF MEDICINAL CHEMISTRY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>462</api:begin-page><api:end-page>476</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2014</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>57</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84893130847"><api:citation-count>6</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains are gaining increasing interest as drug targets. Commercially sourced and de novo synthesized substituted [1,2,4]triazolo[4,3-a]phthalazines are potent inhibitors of both the BET bromodomains such as BRD4 as well as bromodomains outside the BET family such as BRD9, CECR2, and CREBBP. This new series of compounds is the first example of submicromolar inhibitors of bromodomains outside the BET subfamily. Representative compounds are active in cells exhibiting potent cellular inhibition activity in a FRAP model of CREBBP and chromatin association. The compounds described are valuable starting points for discovery of selective bromodomain inhibitors and inhibitors with mixed bromodomain pharmacology. Â© 2013 American Chemical Society.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">40261997100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202578249</api:identifier></api:identifiers></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56017594000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Ludwig Institute for Cancer Research</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">50262281800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55790772400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SJ</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55541113900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36717516700</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>BD</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Kennedy Institute of Rheumatology</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FY</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9536036000</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Ludwig Institute for Cancer Research</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute</api:line><api:line type="organisation">Nuffield Department of Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7FZ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>paul.brennan@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7402304490</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/jm401568s</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/jm401568s"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/jm401568s"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-4804</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-4804"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24313754</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-2623</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0022-2623"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Medicinal Chemistry</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>462</api:begin-page><api:end-page>476</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of diverse bromodomains</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>57</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1021/jm401568s"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Monteiro</api:last-name><api:initials>OP</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Yapp</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>SJ</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>BD</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1021/jm401568s</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1021/jm401568s"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1021/jm401568s"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1520-4804</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1520-4804"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0022-2623</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0022-2623"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Medicinal Chemistry</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>462</api:begin-page><api:end-page>476</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2014</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
[1,2,4]Triazolo[4,3-
]phthalazines: Inhibitors of Diverse Bromodomains</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>57</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0022-2623" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0022-2623"><api:records><api:record source-name="era2012"><api:title>Journal of Medicinal Chemistry</api:title></api:record><api:record source-name="snip"><api:title>Journal of Medicinal Chemistry</api:title></api:record><api:record source-name="era2010"><api:title>Journal of Medicinal Chemistry</api:title></api:record><api:record source-name="science-metrix"><api:title>Journal of Medicinal Chemistry</api:title></api:record><api:record source-name="sjr"><api:title>Journal of Medicinal Chemistry</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Journal of Medicinal Chemistry</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/441659/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/629401</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-12-02T09:13:08.133+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/629401"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/440166"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/440166">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.</a></p></div></content><api:relationship id="629401" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/629401"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="440166" last-modified-when="2014-11-05T15:11:29.033+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/440166" created-when="2013-11-29T08:31:33.837+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:merge-history><api:merge when="2014-05-15T10:12:20.76+01:00"><api:merged-object id="444291" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/444291"/><api:merged-into-object id="440166" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/440166"/></api:merge></api:merge-history><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2013-11-18</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="24248379" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription. Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models. However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting. Here, we report that RVX-208, a compound currently in phase II clinical trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s). Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin. However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription. Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Brotherton</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Diez-Dacal</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="604" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/604"/></api:links><api:last-name>Bountra</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/24248379</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.1310658110</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.1310658110"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.1310658110"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3856850</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>49</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proc Natl Acad Sci U S A</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>ApoA1</api:keyword><api:keyword>epigenetics</api:keyword><api:keyword>microarray</api:keyword><api:keyword>small molecule inhibitor</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Fluorescence Recovery After Photobleaching</api:keyword><api:keyword scheme="mesh">Hep G2 Cells</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Molecular Structure</api:keyword><api:keyword scheme="mesh">Oligonucleotide Array Sequence Analysis</api:keyword><api:keyword scheme="mesh">Protein Binding</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Quinazolines</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>19754</api:begin-page><api:end-page>19759</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>1310658110</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>3</api:day><api:month>12</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>110</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:24248379"><api:citation-count>13</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription. Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models. However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting. Here, we report that RVX-208, a compound currently in phase II clinical trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s). Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin. However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription. Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation. </api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Brotherton</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Diez-Dacal</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="604" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/604"/></api:links><api:last-name>Bountra</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.1310658110</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.1310658110"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.1310658110"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24248379</api:identifier><api:identifier scheme="pmc">PMC3856850</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>49</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proceedings of the National Academy of Sciences of the United States of America</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Quinazolines</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Oligonucleotide Array Sequence Analysis</api:keyword><api:keyword scheme="mesh">Fluorescence Recovery After Photobleaching</api:keyword><api:keyword scheme="mesh">Molecular Structure</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Protein Binding</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Hep G2 Cells</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>19754</api:begin-page><api:end-page>19759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>110</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000327744900034"><api:citation-count>11</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Brotherton</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Diez-Dacal</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Bountra</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="researcherid">B-6412-2014</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000327744900034&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.1310658110</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.1310658110"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.1310658110"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">262OJ</api:identifier><api:identifier scheme="pubmed">24248379</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>49</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>small molecule inhibitor</api:keyword><api:keyword>epigenetics</api:keyword><api:keyword>microarray</api:keyword><api:keyword>ApoA1</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>19754</api:begin-page><api:end-page>19759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>3</api:day><api:month>12</api:month><api:year>2013</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>110</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84889663966"><api:citation-count>14</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription. Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models. However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting. Here, we report that RVX-208, a compound currently in phase II clinical trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s). Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin. However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription. Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202578249</api:identifier></api:identifiers></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36717516700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Brotherton</api:last-name><api:initials>D</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55955312400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55541113900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602850470</api:identifier></api:identifiers></api:person><api:person><api:last-name>Diez-Dacal</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Ludwig Institute for Cancer Research</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35483590200</api:identifier></api:identifiers></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="604" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/604"/></api:links><api:last-name>Bountra</api:last-name><api:initials>C</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003492909</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">40261997100</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7402304490</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7BN</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Ludwig Institute for Cancer Research</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>panagis.filippakopoulos@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.1310658110/-/DCSupplemental</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.1310658110/-/DCSupplemental"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.1310658110/-/DCSupplemental"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">24248379</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>49</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proceedings of the National Academy of Sciences of the United States of America</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>19754</api:begin-page><api:end-page>19759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>3</api:day><api:month>12</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>110</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1073/pnas.1310658110"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wells</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Brotherton</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Martin</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Diez-Dacal</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="604" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/604"/></api:links><api:last-name>Bountra</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Lingard</api:last-name><api:initials>H</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>PE</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.1310658110</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.1310658110"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.1310658110"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>49</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proceedings of the National Academy of Sciences</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>19754</api:begin-page><api:end-page>19759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>3</api:day><api:month>12</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>110</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0027-8424" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"><api:records><api:record source-name="era2012"><api:title>Proceedings of the National Academy of Sciences of USA</api:title></api:record><api:record source-name="snip"><api:title>Proceedings of the National Academy of Sciences of the United States of America</api:title></api:record><api:record source-name="era2010"><api:title>Proceedings of the National Academy of Sciences of USA</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Proceedings of the National Academy of Sciences</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/440166/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/574372</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-06-20T08:45:34.08+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/574372"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/405448"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/405448">Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma</a></p></div></content><api:relationship id="574372" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/574372"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="405448" last-modified-when="2014-10-18T10:37:43.92+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/405448" created-when="2013-06-19T08:41:10.393+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2013-04-01</api:reporting-date-1><api:records><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000316996900014" is-preferred-record="true"><api:citation-count>20</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cheng</api:last-name><api:initials>Z</api:initials></api:person><api:person><api:last-name>Gong</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Ma</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Lu</api:last-name><api:initials>K</api:initials></api:person><api:person><api:last-name>Lu</api:last-name><api:initials>X</api:initials></api:person><api:person><api:last-name>Pierce</api:last-name><api:initials>LA</api:initials></api:person><api:person><api:last-name>Thompson</api:last-name><api:initials>RC</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000316996900014&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/1078-0432.CCR-12-3066</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-12-3066"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/1078-0432.CCR-12-3066"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">118BH</api:identifier><api:identifier scheme="pubmed">23403638</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1078-0432</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CLINICAL CANCER RESEARCH</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1748</api:begin-page><api:end-page>1759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2013</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1078-0432" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"><api:records><api:record source-name="era2012"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="snip"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="era2010"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="science-metrix"><api:title>Clinical cancer research : an official journal of the American Association for Cancer Research</api:title></api:record><api:record source-name="sjr"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Clinical Cancer Research</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/405448/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/553889</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-04-15T09:32:25.133+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/553889"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/394924"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/394924">PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.</a></p></div></content><api:relationship id="553889" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/553889"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="394924" last-modified-when="2014-10-18T11:22:16.047+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/394924" created-when="2013-04-13T21:16:20.41+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2013-04-10</api:reporting-date-1><api:repository-items><api:repository-item repository-id="1" repository-name="ORA"><api:content-file-count>0</api:content-file-count><api:licence-file-count>0</api:licence-file-count><api:status>unknown</api:status><api:repository-files/></api:repository-item></api:repository-items><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="23576556" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromo and extra terminal (BET) proteins (BRD2, BRD3, BRD4, and BRDT) are transcriptional regulators required for efficient expression of several growth promoting and antiapoptotic genes as well as for cell-cycle progression. BET proteins are recruited on transcriptionally active chromatin via their two N-terminal bromodomains (BRD), a protein interaction module that specifically recognizes acetylated lysine residues in histones H3 and H4. Inhibition of the BET-histone interaction results in transcriptional downregulation of a number of oncogenes, providing a novel pharmacologic strategy for the treatment of cancer. Here, we present a potent and highly selective dihydroquinazoline-2-one inhibitor, PFI-1, which efficiently blocks the interaction of BET BRDs with acetylated histone tails. Cocrystal structures showed that PFI-1 acts as an acetyl-lysine (Kac) mimetic inhibitor efficiently occupying the Kac binding site in BRD4 and BRD2. PFI-1 has antiproliferative effects on leukemic cell lines and efficiently abrogates their clonogenic growth. Exposure of sensitive cell lines with PFI-1 results in G1 cell-cycle arrest, downregulation of MYC expression, as well as induction of apoptosis and induces differentiation of primary leukemic blasts. Intriguingly, cells exposed to PFI-1 showed significant downregulation of Aurora B kinase, thus attenuating phosphorylation of the Aurora substrate H3S10, providing an alternative strategy for the specific inhibition of this well-established oncology target.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">Structural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Da Costa</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Thanasopoulou</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fish</api:last-name><api:initials>PV</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>Owen</api:last-name><api:initials>DR</api:initials></api:person><api:person><api:last-name>Bradner</api:last-name><api:initials>JE</api:initials></api:person><api:person><api:last-name>Taniere</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>O'Sullivan</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Stankovic</api:last-name><api:initials>T</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/23576556</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/0008-5472.CAN-12-3292</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/0008-5472.CAN-12-3292"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/0008-5472.CAN-12-3292"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1538-7445</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1538-7445"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3673830</api:identifier><api:identifier scheme="nihms">EMS52724</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>11</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer Res</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Cell Growth Processes</api:keyword><api:keyword scheme="mesh">Child</api:keyword><api:keyword scheme="mesh">Down-Regulation</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Mice, Inbred NOD</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Molecular Targeted Therapy</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Phosphorylation</api:keyword><api:keyword scheme="mesh">Precursor B-Cell Lymphoblastic Leukemia-Lymphoma</api:keyword><api:keyword scheme="mesh">Protein Interaction Mapping</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Quinazolines</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Xenograft Model Antitumor Assays</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>3336</api:begin-page><api:end-page>3346</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>0008-5472.CAN-12-3292</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>6</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>73</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:23576556"><api:citation-count>23</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromo and extra terminal (BET) proteins (BRD2, BRD3, BRD4, and BRDT) are transcriptional regulators required for efficient expression of several growth promoting and antiapoptotic genes as well as for cell-cycle progression. BET proteins are recruited on transcriptionally active chromatin via their two N-terminal bromodomains (BRD), a protein interaction module that specifically recognizes acetylated lysine residues in histones H3 and H4. Inhibition of the BET-histone interaction results in transcriptional downregulation of a number of oncogenes, providing a novel pharmacologic strategy for the treatment of cancer. Here, we present a potent and highly selective dihydroquinazoline-2-one inhibitor, PFI-1, which efficiently blocks the interaction of BET BRDs with acetylated histone tails. Cocrystal structures showed that PFI-1 acts as an acetyl-lysine (Kac) mimetic inhibitor efficiently occupying the Kac binding site in BRD4 and BRD2. PFI-1 has antiproliferative effects on leukemic cell lines and efficiently abrogates their clonogenic growth. Exposure of sensitive cell lines with PFI-1 results in G1 cell-cycle arrest, downregulation of MYC expression, as well as induction of apoptosis and induces differentiation of primary leukemic blasts. Intriguingly, cells exposed to PFI-1 showed significant downregulation of Aurora B kinase, thus attenuating phosphorylation of the Aurora substrate H3S10, providing an alternative strategy for the specific inhibition of this well-established oncology target.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="US"><api:line type="full">Structural Genomics Consortium and Target Discovery Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, USA.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Da Costa</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Thanasopoulou</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fish</api:last-name><api:initials>PV</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>Owen</api:last-name><api:initials>DR</api:initials></api:person><api:person><api:last-name>Bradner</api:last-name><api:initials>JE</api:initials></api:person><api:person><api:last-name>Taniere</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>O'Sullivan</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Stankovic</api:last-name><api:initials>T</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/0008-5472.can-12-3292</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/0008-5472.can-12-3292"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/0008-5472.can-12-3292"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1538-7445</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1538-7445"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">23576556</api:identifier><api:identifier scheme="pmc">PMC3673830</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0008-5472"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>11</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer research</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Mice, Inbred NOD</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Quinazolines</api:keyword><api:keyword scheme="mesh">Nuclear Proteins</api:keyword><api:keyword scheme="mesh">Transcription Factors</api:keyword><api:keyword scheme="mesh">Xenograft Model Antitumor Assays</api:keyword><api:keyword scheme="mesh">Protein Interaction Mapping</api:keyword><api:keyword scheme="mesh">Apoptosis</api:keyword><api:keyword scheme="mesh">Cell Growth Processes</api:keyword><api:keyword scheme="mesh">Down-Regulation</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Phosphorylation</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Child</api:keyword><api:keyword scheme="mesh">Precursor B-Cell Lymphoblastic Leukemia-Lymphoma</api:keyword><api:keyword scheme="mesh">Molecular Targeted Therapy</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>3336</api:begin-page><api:end-page>3346</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>73</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000319736800015"><api:citation-count>24</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Da Costa</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Thanasopoulou</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fish</api:last-name><api:initials>PV</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="researcherid">B-6412-2014</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>Owen</api:last-name><api:initials>DR</api:initials></api:person><api:person><api:last-name>Bradner</api:last-name><api:initials>JE</api:initials></api:person><api:person><api:last-name>Taniere</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>O'Sullivan</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Stankovic</api:last-name><api:initials>T</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000319736800015&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/0008-5472.CAN-12-3292</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/0008-5472.CAN-12-3292"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/0008-5472.CAN-12-3292"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">155GV</api:identifier><api:identifier scheme="pubmed">23576556</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0008-5472"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>11</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CANCER RESEARCH</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>3336</api:begin-page><api:end-page>3346</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>6</api:month><api:year>2013</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>73</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84878565710"><api:citation-count>25</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromo and extra terminal (BET) proteins (BRD2, BRD3, BRD4, and BRDT) are transcriptional regulators required for efficient expression of several growth promoting and antiapoptotic genes as well as for cell-cycle progression. BET proteins are recruited on transcriptionally active chromatin via their two N-terminal bromodomains (BRD), a protein interaction module that specifically recognizes acetylated lysine residues in histones H3 and H4. Inhibition of the BET-histone interaction results in transcriptional downregulation of a number of oncogenes, providing a novel pharmacologic strategy for the treatment of cancer. Here, we present a potent and highly selective dihydroquinazoline-2-one inhibitor, PFI-1, which efficiently blocks the interaction of BET BRDs with acetylated histone tails. Cocrystal structures showed that PFI-1 acts as an acetyl-lysine (Kac) mimetic inhibitor efficiently occupying the Kac binding site in BRD4 and BRD2. PFI-1 has antiproliferative effects on leukemic cell lines and efficiently abrogates their clonogenic growth. Exposure of sensitive cell lines with PFI-1 results in G1 cellcycle arrest, downregulation of MYC expression, as well as induction of apoptosis and induces differentiation of primary leukemic blasts. Intriguingly, cells exposed to PFI-1 showed significant downregulation of Aurora B kinase, thus attenuating phosphorylation of the Aurora substrate H3S10, providing an alternative strategy for the specific inhibition of this well-established oncology target. Â© 2013 American Association for Cancer Research.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Da Costa</api:last-name><api:initials>D</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">School of Cancer Sciences</api:line><api:line type="organisation">University of Birmingham</api:line><api:line type="city">Birmingham B15 2TT</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55755693800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Thanasopoulou</api:last-name><api:initials>A</api:initials><api:addresses><api:address iso-country-code="CH"><api:line type="organisation">Department of Biomedicine</api:line><api:line type="organisation">University of Basel</api:line><api:line type="organisation">Basel University Children's Hospital</api:line><api:line type="street-address">Hebelstrasse 20</api:line><api:line type="city">CH - 4031 Basel</api:line><api:line type="country">che</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">26649312000</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fish</api:last-name><api:initials>PV</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Pfizer Worldwide Medicinal Chemistry</api:line><api:line type="organisation">Pfizer Worldwide RandD</api:line><api:line type="street-address">Ramsgate Road</api:line><api:line type="city">Sandwich</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005747441</api:identifier></api:identifiers></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37081848300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7402304490</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Pfizer Worldwide Medicinal Chemistry</api:line><api:line type="organisation">Pfizer Worldwide RandD</api:line><api:line type="street-address">Ramsgate Road</api:line><api:line type="city">Sandwich</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603710592</api:identifier></api:identifiers></api:person><api:person><api:last-name>Owen</api:last-name><api:initials>DR</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Pfizer Worldwide Medicinal Chemistry</api:line><api:line type="organisation">Pfizer Worldwide RandD</api:line><api:line type="street-address">Ramsgate Road</api:line><api:line type="city">Sandwich</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56212366900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Bradner</api:last-name><api:initials>JE</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Medical Oncology</api:line><api:line type="organisation">Dana-Farber Cancer Institute</api:line><api:line type="city">Boston, MA</api:line><api:line type="country">usa</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">Department of Medicine</api:line><api:line type="organisation">Harvard Medical School</api:line><api:line type="city">Boston, MA</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">10243379500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Taniere</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Cellular Pathology</api:line><api:line type="organisation">Queen Elizabeth Medical Centre</api:line><api:line type="city">Birmingham</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603758254</api:identifier></api:identifiers></api:person><api:person><api:last-name>O'Sullivan</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Department of Cellular Pathology</api:line><api:line type="organisation">Queen Elizabeth Medical Centre</api:line><api:line type="city">Birmingham</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56174745500</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="CH"><api:line type="organisation">Department of Biomedicine</api:line><api:line type="organisation">University of Basel</api:line><api:line type="organisation">Basel University Children's Hospital</api:line><api:line type="street-address">Hebelstrasse 20</api:line><api:line type="city">CH - 4031 Basel</api:line><api:line type="country">che</api:line></api:address></api:addresses><api:email-address>j.schwaller@unibas.ch</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">6701597458</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stankovic</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">School of Cancer Sciences</api:line><api:line type="organisation">University of Birmingham</api:line><api:line type="city">Birmingham B15 2TT</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>t.stankovic@bham.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7004841290</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford, Oxon OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Target Discovery Institute</api:line><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">Department of Biochemistry and Molecular Biology</api:line><api:line type="organisation">School of Medicine and Health Sciences</api:line><api:line type="organisation">George Washington University</api:line><api:line type="city">Washington, DC</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/0008-5472.CAN-12-3292</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/0008-5472.CAN-12-3292"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/0008-5472.CAN-12-3292"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1538-7445</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1538-7445"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">23576556</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0008-5472"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>11</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer Research</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>3336</api:begin-page><api:end-page>3346</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>6</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>PFI-1, a highly selective protein interaction inhibitor, targeting BET bromodomains</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>73</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1158/0008-5472.CAN-12-3292"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Da Costa</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Thanasopoulou</api:last-name><api:initials>A</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Fish</api:last-name><api:initials>PV</api:initials></api:person><api:person><api:last-name>Philpott</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3519" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3519"/></api:links><api:last-name>Brennan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Bunnage</api:last-name><api:initials>ME</api:initials></api:person><api:person><api:last-name>Owen</api:last-name><api:initials>DR</api:initials></api:person><api:person><api:last-name>Bradner</api:last-name><api:initials>JE</api:initials></api:person><api:person><api:last-name>Taniere</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>O'Sullivan</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Stankovic</api:last-name><api:initials>T</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/0008-5472.CAN-12-3292</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/0008-5472.CAN-12-3292"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/0008-5472.CAN-12-3292"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1538-7445</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1538-7445"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0008-5472</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0008-5472"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>11</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cancer Research</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>3336</api:begin-page><api:end-page>3346</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>6</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>73</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0008-5472" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0008-5472"><api:records><api:record source-name="era2012"><api:title>Cancer Research</api:title></api:record><api:record source-name="snip"><api:title>Cancer Research</api:title></api:record><api:record source-name="era2010"><api:title>Cancer Research</api:title></api:record><api:record source-name="science-metrix"><api:title>Cancer Research</api:title></api:record><api:record source-name="sjr"><api:title>Cancer Research</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Cancer Research</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/394924/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/547919</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-04-02T11:52:07.357+01:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/547919"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/371150"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Inhibition of BET bromodomain targets genetically diverse glioblastoma.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/371150">Inhibition of BET bromodomain targets genetically diverse glioblastoma.</a></p></div></content><api:relationship id="547919" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/547919"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="371150" last-modified-when="2014-10-16T00:06:42.69+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/371150" created-when="2013-01-08T12:22:10.773+00:00" type-id="4" type="conference"><!--Publication type 4 is "conference"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2012-10-01</api:reporting-date-1><api:repository-items><api:repository-item repository-id="1" repository-name="ORA"><api:content-file-count>0</api:content-file-count><api:licence-file-count>0</api:licence-file-count><api:status>unknown</api:status><api:repository-files/></api:repository-item></api:repository-items><api:records><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000310971300117" is-preferred-record="true"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cheng</api:last-name><api:initials>Z</api:initials></api:person><api:person><api:last-name>Gong</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Ma</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Ller-Knapp</api:last-name><api:initials>SM</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000310971300117&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">035TH</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1522-8517</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1522-8517"/></api:links></api:field><api:field name="journal" type="text" display-name="Published proceedings"><api:text>NEURO-ONCOLOGY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>28</api:begin-page><api:end-page>28</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>10</api:month><api:year>2012</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>INHIBITION OF BET BROMODOMAIN TARGETS GENETICALLY DIVERSE GLIOBLASTOMA</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>14</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:23403638"><api:citation-count>20</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>PURPOSE: Glioblastoma is refractory to conventional therapies. The bromodomain and extraterminal domain (BET) proteins are epigenetic readers that selectively bind to acetylated lysine residues on histone tails. These proteins recently emerged as important therapeutic targets in NUT midline carcinoma and several types of hematopoietic cancers. In this study, the therapeutic potential of a novel BET bromodomain inhibitor, JQ1, was assessed in a panel of genetically heterogeneous glioblastoma samples. EXPERIMENTAL DESIGN: The antineoplastic effects of JQ1 were shown using ex vivo cultures derived from primary glioblastoma xenograft lines and surgical specimens of different genetic background. The in vivo efficacy was assessed in orthotopic glioblastoma tumors. RESULTS: We showed that JQ1 induced marked G1 cell-cycle arrest and apoptosis, which was phenocopied by knockdown of individual BET family members. JQ1 treatment resulted in significant changes in expression of genes that play important roles in glioblastoma such as c-Myc, p21(CIP1/WAF1), hTERT, Bcl-2, and Bcl-xL. Unlike the observations in some hematopoietic cancer cell lines, exogenous c-Myc did not significantly protect glioblastoma cells against JQ1. In contrast, ectopically expressed Bcl-xL partially rescued cells from JQ1-induced apoptosis, and knockdown of p21(CIP1/WAF1) attenuated JQ1-induced cell-cycle arrest. Cells genetically engineered for Akt hyperactivation or p53/Rb inactivation did not compromise JQ1 efficacy, suggesting that these frequently mutated signaling pathways may not confer resistance to JQ1. Furthermore, JQ1 significantly repressed growth of orthotopic glioblastoma tumors. CONCLUSION: Our results suggest potentially broad therapeutic use of BET bromodomain inhibitors for treating genetically diverse glioblastoma tumors.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="US"><api:line type="full">Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cheng</api:last-name><api:initials>Z</api:initials></api:person><api:person><api:last-name>Gong</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Ma</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Lu</api:last-name><api:initials>K</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="632" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/632"/></api:links><api:last-name>Lu</api:last-name><api:initials>X</api:initials></api:person><api:person><api:last-name>Pierce</api:last-name><api:initials>LA</api:initials></api:person><api:person><api:last-name>Thompson</api:last-name><api:initials>RC</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/1078-0432.ccr-12-3066</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/1078-0432.ccr-12-3066"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/1078-0432.ccr-12-3066"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">23403638</api:identifier><api:identifier scheme="pmc">PMC4172367</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1078-0432</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7</api:text></api:field><api:field name="journal" type="text" display-name="Published proceedings"><api:text>Clinical cancer research : an official journal of the American Association for Cancer Research</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Cell Line, Tumor</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Glioblastoma</api:keyword><api:keyword scheme="mesh">Disease Models, Animal</api:keyword><api:keyword scheme="mesh">Disease Progression</api:keyword><api:keyword scheme="mesh">Azepines</api:keyword><api:keyword scheme="mesh">Triazoles</api:keyword><api:keyword scheme="mesh">Protein-Serine-Threonine Kinases</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins c-myc</api:keyword><api:keyword scheme="mesh">Protein Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Xenograft Model Antitumor Assays</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Cell Proliferation</api:keyword><api:keyword scheme="mesh">Cell Survival</api:keyword><api:keyword scheme="mesh">Transcription, Genetic</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh">RNA Interference</api:keyword><api:keyword scheme="mesh">Drug Resistance, Neoplasm</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Gene Knockdown Techniques</api:keyword></api:keywords></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1748</api:begin-page><api:end-page>1759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inhibition of BET bromodomain targets genetically diverse glioblastoma.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="23403638"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Glioblastoma is refractory to conventional therapies. The bromodomain and extraterminal domain (BET) proteins are epigenetic readers that selectively bind to acetylated lysine residues on histone tails. These proteins recently emerged as important therapeutic targets in NUT midline carcinoma and several types of hematopoietic cancers. In this study, the therapeutic potential of a novel BET bromodomain inhibitor, JQ1, was assessed in a panel of genetically heterogeneous glioblastoma samples.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cheng</api:last-name><api:initials>Z</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="full">Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Gong</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Ma</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Lu</api:last-name><api:initials>K</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="632" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/632"/></api:links><api:last-name>Lu</api:last-name><api:initials>X</api:initials></api:person><api:person><api:last-name>Pierce</api:last-name><api:initials>LA</api:initials></api:person><api:person><api:last-name>Thompson</api:last-name><api:initials>RC</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/23403638</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/1078-0432.CCR-12-3066</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-12-3066"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/1078-0432.CCR-12-3066"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC4172367</api:identifier><api:identifier scheme="nihms">EMS60218</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1078-0432</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7</api:text></api:field><api:field name="journal" type="text" display-name="Published proceedings"><api:text>Clin Cancer Res</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Azepines</api:keyword><api:keyword scheme="mesh">Cell Line, Tumor</api:keyword><api:keyword scheme="mesh">Cell Proliferation</api:keyword><api:keyword scheme="mesh">Cell Survival</api:keyword><api:keyword scheme="mesh">Disease Models, Animal</api:keyword><api:keyword scheme="mesh">Disease Progression</api:keyword><api:keyword scheme="mesh">Drug Resistance, Neoplasm</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation, Neoplastic</api:keyword><api:keyword scheme="mesh">Gene Knockdown Techniques</api:keyword><api:keyword scheme="mesh">Glioblastoma</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mice</api:keyword><api:keyword scheme="mesh">Protein Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Protein-Serine-Threonine Kinases</api:keyword><api:keyword scheme="mesh">Proto-Oncogene Proteins c-myc</api:keyword><api:keyword scheme="mesh">RNA Interference</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Transcription, Genetic</api:keyword><api:keyword scheme="mesh">Triazoles</api:keyword><api:keyword scheme="mesh">Xenograft Model Antitumor Assays</api:keyword></api:keywords></api:field><api:field name="location" type="text" display-name="Conference place"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1748</api:begin-page><api:end-page>1759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inhibition of BET bromodomain targets genetically diverse glioblastoma.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84877097843"><api:citation-count>20</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Purpose: Glioblastoma is refractory to conventional therapies. The bromodomain and extraterminal domain (BET) proteins are epigenetic readers that selectively bind to acetylated lysine residues on histone tails. These proteins recently emerged as important therapeutic targets in NUT midline carcinoma and several types of hematopoietic cancers. In this study, the therapeutic potential of a novel BET bromodomain inhibitor, JQ1, was assessed in a panel of genetically heterogeneous glioblastoma samples. Experimental Design: The antineoplastic effects of JQ1 were shown using ex vivo cultures derived from primary glioblastoma xenograft lines and surgical specimens of different genetic background. The in vivo efficacy was assessed in orthotopic glioblastoma tumors. Results: We showed that JQ1 induced marked G1 cell-cycle arrest and apoptosis, which was phenocopied by knockdown of individual BET family members. JQ1 treatment resulted in significant changes in expression of genes that play important roles in glioblastoma such as c-Myc, p21 CIP1/WAF1, hTERT, Bcl-2, and Bcl-xL. Unlike the observations in some hematopoietic cancer cell lines, exogenous c-Myc did not significantly protect glioblastoma cells against JQ1. In contrast, ectopically expressed Bcl-xL partially rescued cells from JQ1-induced apoptosis, and knockdown of p21 CIP1/WAF1 attenuated JQ1-induced cell-cycle arrest. Cells genetically engineered for Akt hyperactivation or p53/Rb inactivation did not compromise JQ1 efficacy, suggesting that these frequently mutated signaling pathways may not confer resistance to JQ1. Furthermore, JQ1 significantly repressed growth of orthotopic glioblastoma tumors. Conclusion: Our results suggest potentially broad therapeutic use of BET bromodomain inhibitors for treating genetically diverse glioblastoma tumors. Â©2013 AACR.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cheng</api:last-name><api:initials>Z</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Neurological Surgery</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address><api:address iso-country-code="CN"><api:line type="organisation">Department of Oncology</api:line><api:line type="organisation">Second Affiliated Hospital</api:line><api:line type="organisation">Nanjing Medical University</api:line><api:line type="city">Nanjing</api:line><api:line type="country">chn</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7401815447</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gong</api:last-name><api:initials>Y</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Neurological Surgery</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55675124600</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ma</api:last-name><api:initials>Y</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Neurological Surgery</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55674851500</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lu</api:last-name><api:initials>K</api:initials><api:addresses><api:address iso-country-code="CN"><api:line type="organisation">Department of Oncology</api:line><api:line type="organisation">First Affiliated Hospital</api:line><api:line type="organisation">Nanjing Medical University</api:line><api:line type="city">Nanjing</api:line><api:line type="country">chn</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7402892782</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="632" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/632"/></api:links><api:last-name>Lu</api:last-name><api:initials>X</api:initials><api:addresses><api:address iso-country-code="CN"><api:line type="organisation">Department of Geriatrics</api:line><api:line type="organisation">Second Affiliated Hospital</api:line><api:line type="organisation">Nanjing Medical University</api:line><api:line type="city">Nanjing</api:line><api:line type="country">chn</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55260474900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Pierce</api:last-name><api:initials>LA</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Neurological Surgery</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7102977188</api:identifier></api:identifiers></api:person><api:person><api:last-name>Thompson</api:last-name><api:initials>RC</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Neurological Surgery</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55482221700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Neurological Surgery</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">Department of Cancer Biology</api:line><api:line type="organisation">Vanderbilt University Medical Center</api:line><api:line type="city">Nashville, TN</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:email-address>jialiang.wang@vanderbilt.edu</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">35214069300</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/1078-0432.CCR-12-3066</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-12-3066"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/1078-0432.CCR-12-3066"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1557-3265</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1557-3265"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">23403638</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1078-0432</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7</api:text></api:field><api:field name="journal" type="text" display-name="Published proceedings"><api:text>Clinical Cancer Research</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1748</api:begin-page><api:end-page>1759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Inhibition of BET bromodomain targets genetically diverse glioblastoma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1158/1078-0432.CCR-12-3066"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Cheng</api:last-name><api:initials>Z</api:initials></api:person><api:person><api:last-name>Gong</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Ma</api:last-name><api:initials>Y</api:initials></api:person><api:person><api:last-name>Lu</api:last-name><api:initials>K</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="632" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/632"/></api:links><api:last-name>Lu</api:last-name><api:initials>X</api:initials></api:person><api:person><api:last-name>Pierce</api:last-name><api:initials>LA</api:initials></api:person><api:person><api:last-name>Thompson</api:last-name><api:initials>RC</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Wang</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1158/1078-0432.CCR-12-3066</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1158/1078-0432.CCR-12-3066"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1158/1078-0432.CCR-12-3066"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1557-3265</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1557-3265"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1078-0432</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>7</api:text></api:field><api:field name="journal" type="text" display-name="Published proceedings"><api:text>Clinical Cancer Research</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1748</api:begin-page><api:end-page>1759</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>4</api:month><api:year>2013</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1078-0432" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1078-0432"><api:records><api:record source-name="era2012"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="snip"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="era2010"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="science-metrix"><api:title>Clinical cancer research : an official journal of the American Association for Cancer Research</api:title></api:record><api:record source-name="sjr"><api:title>Clinical Cancer Research</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Clinical Cancer Research</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/371150/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/529521</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-02-06T11:38:04.413+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/529521"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/379148"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Open-access public-private partnerships to enable drug discovery-New approaches</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/379148">Open-access public-private partnerships to enable drug discovery-New approaches</a></p></div></content><api:relationship id="529521" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/529521"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="379148" last-modified-when="2014-09-07T01:51:55.693+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/379148" created-when="2013-02-06T09:45:38.867+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-01-01</api:reporting-date-1><api:records><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-77749246598" is-preferred-record="true"><api:citation-count>0</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The productivity of the pharmaceutical industry, as assessed by the number of NMEs produced per US dollar spent in R&amp;D, has been in steady decline during the past 40 years. This decline in productivity not only poses a significant challenge to the pharmaceutical industry, but also to society because of the importance of developing drugs for the treatment of unmet medical needs. The major challenge in progressing a new drug to the market is the successful completion of clinical trials. However, the failure rate of drugs entering trials has not decreased, despite various technological and scientific breakthroughs in recent decades, and despite intense target validation efforts. This lack of success suggests limitations in the fundamental understanding of target biology and human pharmacology. One contributing factor may be the traditional secrecy of the pharmaceutical sector, a characteristic that does not promote scientific discovery in an optimal manner. Access to broader knowledge relating to target biology and human pharmacology is difficult to obtain because interactions between researchers in industry and academia are typically restricted to closed collaborations in which the knowledge gained is confidential.However, open-access collaborative partnerships are gaining momentum in industry, and are also favored by funding agencies. Such open-access collaborations may be a powerful alternative to closed collaborations; the sharing of early-stage research data is expected to enable scientific discovery by engaging a broader section of the scientific community in the exploration of new findings. Potentially, the sharing of data could contribute to an increased understanding of biological processes and a decrease in the attrition of clinical programs. Â© Thomson Reuters (Scientific) Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Weigelt</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="SE"><api:line type="organisation">Karolinska Institutet</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Department of Medical Biochemistry and Biophysics</api:line><api:line type="city">171 77 Stockholm</api:line><api:line type="country">swe</api:line></api:address></api:addresses><api:email-address>johan.weigelt@ki.se</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7005220379</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0218-625X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0218-625X"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Surface Review and Letters</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Drug discovery</api:keyword><api:keyword>Open-access science</api:keyword><api:keyword>Public-private partnership</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>175</api:begin-page><api:end-page>180</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Open-access public-private partnerships to enable drug discovery-New approaches</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Conference Proceeding</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>16</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0218-625X" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0218-625X"><api:records><api:record source-name="era2012"><api:title>Surface Review and Letters</api:title></api:record><api:record source-name="snip"><api:title>Surface Review and Letters</api:title></api:record><api:record source-name="era2010"><api:title>Surface Review and Letters</api:title></api:record><api:record source-name="science-metrix"><api:title>Surface Review &amp; Letters</api:title></api:record><api:record source-name="sjr"><api:title>Surface Review and Letters</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Surface Review and Letters</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/379148/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/522801</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-02-03T18:19:24.057+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/522801"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/375484"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Open-access public-private partnerships to enable drug discovery--new approaches.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/375484">Open-access public-private partnerships to enable drug discovery--new approaches.</a></p></div></content><api:relationship id="522801" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/522801"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="375484" last-modified-when="2014-09-07T02:01:36.27+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/375484" created-when="2013-02-01T06:14:38.703+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2010-03-01</api:reporting-date-1><api:records><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000274930800012" is-preferred-record="true"><api:citation-count>3</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Weigelt</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000274930800012&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">560VD</api:identifier><api:identifier scheme="pubmed">20191434</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1369-7056</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1369-7056"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>IDRUGS</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Drug discovery</api:keyword><api:keyword>open-access science</api:keyword><api:keyword>public-private partnership</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>175</api:begin-page><api:end-page>180</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Open-access public-private partnerships to enable drug discovery - New approaches</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:20191434"><api:citation-count>2</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The productivity of the pharmaceutical industry, as assessed by the number of NMEs produced per US dollar spent in R&amp;D, has been in steady decline during the past 40 years. This decline in productivity not only poses a significant challenge to the pharmaceutical industry, but also to society because of the importance of developing drugs for the treatment of unmet medical needs. The major challenge in progressing a new drug to the market is the successful completion of clinical trials. However, the failure rate of drugs entering trials has not decreased, despite various technological and scientific breakthroughs in recent decades, and despite intense target validation efforts. This lack of success suggests limitations in the fundamental understanding of target biology and human pharmacology. One contributing factor may be the traditional secrecy of the pharmaceutical sector, a characteristic that does not promote scientific discovery in an optimal manner. Access to broader knowledge relating to target biology and human pharmacology is difficult to obtain because interactions between researchers in industry and academia are typically restricted to closed collaborations in which the knowledge gained is confidential.However, open-access collaborative partnerships are gaining momentum in industry, and are also favored by funding agencies. Such open-access collaborations may be a powerful alternative to closed collaborations; the sharing of early-stage research data is expected to enable scientific discovery by engaging a broader section of the scientific community in the exploration of new findings. Potentially, the sharing of data could contribute to an increased understanding of biological processes and a decrease in the attrition of clinical programs.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="SE"><api:line type="full">Karolinska Institutet, Structural Genomics Consortium, Department of Medical Biochemistry and Biophysics, 171 77 Stockholm, Sweden.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Weigelt</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>2040-3410</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-3410"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">20191434</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1369-7056</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1369-7056"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>IDrugs : the investigational drugs journal</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Treatment Failure</api:keyword><api:keyword scheme="mesh">Disclosure</api:keyword><api:keyword scheme="mesh">Cooperative Behavior</api:keyword><api:keyword scheme="mesh">Private Sector</api:keyword><api:keyword scheme="mesh">Public Sector</api:keyword><api:keyword scheme="mesh">Access to Information</api:keyword><api:keyword scheme="mesh">Drug Industry</api:keyword><api:keyword scheme="mesh">Efficiency, Organizational</api:keyword><api:keyword scheme="mesh">Organizational Objectives</api:keyword><api:keyword scheme="mesh">Interinstitutional Relations</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh">Drug Discovery</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>175</api:begin-page><api:end-page>180</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Open-access public-private partnerships to enable drug discovery--new approaches.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="20191434"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The productivity of the pharmaceutical industry, as assessed by the number of NMEs produced per US dollar spent in R&amp;D, has been in steady decline during the past 40 years. This decline in productivity not only poses a significant challenge to the pharmaceutical industry, but also to society because of the importance of developing drugs for the treatment of unmet medical needs. The major challenge in progressing a new drug to the market is the successful completion of clinical trials. However, the failure rate of drugs entering trials has not decreased, despite various technological and scientific breakthroughs in recent decades, and despite intense target validation efforts. This lack of success suggests limitations in the fundamental understanding of target biology and human pharmacology. One contributing factor may be the traditional secrecy of the pharmaceutical sector, a characteristic that does not promote scientific discovery in an optimal manner. Access to broader knowledge relating to target biology and human pharmacology is difficult to obtain because interactions between researchers in industry and academia are typically restricted to closed collaborations in which the knowledge gained is confidential.However, open-access collaborative partnerships are gaining momentum in industry, and are also favored by funding agencies. Such open-access collaborations may be a powerful alternative to closed collaborations; the sharing of early-stage research data is expected to enable scientific discovery by engaging a broader section of the scientific community in the exploration of new findings. Potentially, the sharing of data could contribute to an increased understanding of biological processes and a decrease in the attrition of clinical programs.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="SE"><api:line type="full">Karolinska Institutet, Structural Genomics Consortium, Department of Medical Biochemistry and Biophysics, 171 77 Stockholm, Sweden.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Weigelt</api:last-name><api:initials>J</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/20191434</api:text></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>2040-3410</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/2040-3410"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>IDrugs</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Access to Information</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh">Cooperative Behavior</api:keyword><api:keyword scheme="mesh">Disclosure</api:keyword><api:keyword scheme="mesh">Drug Discovery</api:keyword><api:keyword scheme="mesh">Drug Industry</api:keyword><api:keyword scheme="mesh">Efficiency, Organizational</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Interinstitutional Relations</api:keyword><api:keyword scheme="mesh">Organizational Objectives</api:keyword><api:keyword scheme="mesh">Private Sector</api:keyword><api:keyword scheme="mesh">Public Sector</api:keyword><api:keyword scheme="mesh">Treatment Failure</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>175</api:begin-page><api:end-page>180</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Open-access public-private partnerships to enable drug discovery--new approaches.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-77749309299"><api:citation-count>5</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The productivity of the pharmaceutical industry, as assessed by the number of NMEs produced per US dollar spent in R&amp;D, has been in steady decline during the past 40 years. This decline in productivity not only poses a significant challenge to the pharmaceutical industry, but also to society because of the importance of developing drugs for the treatment of unmet medical needs. The major challenge in progressing a new drug to the market is the successful completion of clinical trials. However, the failure rate of drugs entering trials has not decreased, despite various technological and scientific breakthroughs in recent decades, and despite intense target validation efforts. This lack of success suggests limitations in the fundamental understanding of target biology and human pharmacology. One contributing factor may be the traditional secrecy of the pharmaceutical sector, a characteristic that does not promote scientific discovery in an optimal manner. Access to broader knowledge relating to target biology and human pharmacology is difficult to obtain because interactions between researchers in industry and academia are typically restricted to closed collaborations in which the knowledge gained is confidential.However, open-access collaborative partnerships are gaining momentum in industry, and are also favored by funding agencies. Such open-access collaborations may be a powerful alternative to closed collaborations; the sharing of early-stage research data is expected to enable scientific discovery by engaging a broader section of the scientific community in the exploration of new findings. Potentially, the sharing of data could contribute to an increased understanding of biological processes and a decrease in the attrition of clinical programs. Â© Thomson Reuters (Scientific) Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Weigelt</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="SE"><api:line type="organisation">Karolinska Institutet, Structural Genomics Consortium</api:line><api:line type="organisation">Department of Medical Biochemistry and Biophysics</api:line><api:line type="city">171 77 Stockholm</api:line><api:line type="country">swe</api:line></api:address></api:addresses><api:email-address>johan.weigelt@ki.se</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7005220379</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">20191434</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1369-7056</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1369-7056"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>IDrugs</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Drug discovery</api:keyword><api:keyword>Open-access science</api:keyword><api:keyword>Public-private partnership</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>175</api:begin-page><api:end-page>180</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Open-access public-private partnerships to enable drug discovery - New approaches</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>13</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1369-7056" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1369-7056"><api:records><api:record source-name="era2012"><api:title>IDrugs: the Investigational Drugs Journal</api:title></api:record><api:record source-name="snip"><api:title>IDrugs : the investigational drugs journal</api:title></api:record><api:record source-name="era2010"><api:title>IDrugs: the Investigational Drugs Journal</api:title></api:record><api:record source-name="science-metrix"><api:title>Idrugs</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>IDrugs</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/375484/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/520204</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-01-10T17:11:42.583+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/520204"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/356304"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Epigenetic chemical probes.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/356304">Epigenetic chemical probes.</a></p></div></content><api:relationship id="520204" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/520204"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="356304" last-modified-when="2014-09-12T12:38:01.037+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/356304" created-when="2012-10-27T19:29:30.44+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2012-10-24</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="23093316" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Epigenetic control of gene expression occurs at two distinctlevels: DNA methylation and histone modification. Over thepast 10 years, the discovery of epigenetic targets has acceleratedto the point where more than 400 domains have beenidentified that are involved in either DNA methylation, themodification of histones (and some nonhistones), or translationof these modifications into changes in gene expression</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, University of Oxford, Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Brown</api:last-name><api:initials>PJ</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/23093316</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/clpt.2012.154</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/clpt.2012.154"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/clpt.2012.154"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-6535</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1532-6535"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clin Pharmacol Ther</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">DNA Methylation</api:keyword><api:keyword scheme="mesh">Epigenesis, Genetic</api:keyword><api:keyword scheme="mesh">Epigenomics</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation</api:keyword><api:keyword scheme="mesh">Histone Acetyltransferases</api:keyword><api:keyword scheme="mesh">Histone Deacetylases</api:keyword><api:keyword scheme="mesh">Histone-Lysine N-Methyltransferase</api:keyword><api:keyword scheme="mesh">Histones</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Lysine</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>689</api:begin-page><api:end-page>693</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>clpt2012154</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Epigenetic chemical probes.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>92</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:23093316"><api:citation-count>3</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Epigenetic control of gene expression occurs at two distinctlevels: DNA methylation and histone modification. Over thepast 10 years, the discovery of epigenetic targets has acceleratedto the point where more than 400 domains have beenidentified that are involved in either DNA methylation, themodification of histones (and some nonhistones), or translationof these modifications into changes in gene expression</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, University of Oxford, Oxford, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Brown</api:last-name><api:initials>PJ</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/clpt.2012.154</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/clpt.2012.154"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/clpt.2012.154"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-6535</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1532-6535"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">23093316</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-9236</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0009-9236"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical pharmacology and therapeutics</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Histone Deacetylases</api:keyword><api:keyword scheme="mesh">Histone-Lysine N-Methyltransferase</api:keyword><api:keyword scheme="mesh">Lysine</api:keyword><api:keyword scheme="mesh">Histones</api:keyword><api:keyword scheme="mesh">DNA Methylation</api:keyword><api:keyword scheme="mesh">Gene Expression Regulation</api:keyword><api:keyword scheme="mesh">Epigenesis, Genetic</api:keyword><api:keyword scheme="mesh">Histone Acetyltransferases</api:keyword><api:keyword scheme="mesh">Epigenomics</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>689</api:begin-page><api:end-page>693</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Epigenetic chemical probes.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>92</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000311283400008"><api:citation-count>8</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Brown</api:last-name><api:initials>PJ</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000311283400008&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/clpt.2012.154</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/clpt.2012.154"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/clpt.2012.154"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">039YE</api:identifier><api:identifier scheme="pubmed">23093316</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-9236</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0009-9236"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CLINICAL PHARMACOLOGY &amp; THERAPEUTICS</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>689</api:begin-page><api:end-page>693</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2012</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Epigenetic Chemical Probes</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>92</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84867636902"><api:citation-count>0</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Brown</api:last-name><api:initials>PJ</api:initials></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-6535</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1532-6535"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-9236</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0009-9236"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical Pharmacology and Therapeutics</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Epigenetic Chemical Probes</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1038/clpt.2012.154"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Brown</api:last-name><api:initials>PJ</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/clpt.2012.154</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/clpt.2012.154"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/clpt.2012.154"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-6535</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1532-6535"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-9236</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0009-9236"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Clinical Pharmacology &amp; Therapeutics</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>689</api:begin-page><api:end-page>693</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Epigenetic Chemical Probes</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>92</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0009-9236" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0009-9236"><api:records><api:record source-name="era2012"><api:title>Clinical Pharmacology and Therapeutics</api:title></api:record><api:record source-name="snip"><api:title>Clinical Pharmacology and Therapeutics</api:title></api:record><api:record source-name="era2010"><api:title>Clinical Pharmacology and Therapeutics</api:title></api:record><api:record source-name="science-metrix"><api:title>Clinical Pharmacology &amp; Therapeutics (Nature)</api:title></api:record><api:record source-name="sjr"><api:title>Clinical Pharmacology and Therapeutics</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Clinical Pharmacology and Therapeutics</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/356304/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/520205</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-01-10T17:14:26.36+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/520205"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322665"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Histone recognition and large-scale structural analysis of the human bromodomain family.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322665">Histone recognition and large-scale structural analysis of the human bromodomain family.</a></p></div></content><api:relationship id="520205" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/520205"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="322665" last-modified-when="2014-11-04T00:40:47.733+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322665" created-when="2012-04-14T05:30:20.913+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2012-03-30</api:reporting-date-1><api:repository-items><api:repository-item repository-id="1" repository-name="ORA"><api:content-file-count>0</api:content-file-count><api:licence-file-count>0</api:licence-file-count><api:status>unknown</api:status><api:repository-files/></api:repository-item></api:repository-items><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="22464331" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains (BRDs) are protein interaction modules that specifically recognize Îµ-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening ofÂ more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK. panagis.filippakopoulos@sgc.ox.ac.uk</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Mangos</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>JP</api:initials></api:person><api:person><api:last-name>Barsyte-Lovejoy</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Volkmer</api:last-name><api:initials>R</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Pawson</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>AC</api:initials></api:person><api:person><api:last-name>Arrowsmith</api:last-name><api:initials>CH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/22464331</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2012.02.013</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2012.02.013"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2012.02.013"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1097-4172</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1097-4172"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3326523</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Acetylation</api:keyword><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Genome, Human</api:keyword><api:keyword scheme="mesh">Histones</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Lysine</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Molecular Sequence Data</api:keyword><api:keyword scheme="mesh">Phylogeny</api:keyword><api:keyword scheme="mesh">Protein Interaction Domains and Motifs</api:keyword><api:keyword scheme="mesh">Protein Processing, Post-Translational</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Proteome</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>214</api:begin-page><api:end-page>231</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0092-8674(12)00213-9</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>30</api:day><api:month>3</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Histone recognition and large-scale structural analysis of the human bromodomain family.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>149</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:22464331"><api:citation-count>106</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains (BRDs) are protein interaction modules that specifically recognize Îµ-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening ofÂ more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK. panagis.filippakopoulos@sgc.ox.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Mangos</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>JP</api:initials></api:person><api:person><api:last-name>Barsyte-Lovejoy</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Volkmer</api:last-name><api:initials>R</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Pawson</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>AC</api:initials></api:person><api:person><api:last-name>Arrowsmith</api:last-name><api:initials>CH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2012.02.013</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2012.02.013"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2012.02.013"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1097-4172</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1097-4172"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">22464331</api:identifier><api:identifier scheme="pmc">PMC3326523</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Lysine</api:keyword><api:keyword scheme="mesh">Histones</api:keyword><api:keyword scheme="mesh">Proteome</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Phylogeny</api:keyword><api:keyword scheme="mesh">Protein Processing, Post-Translational</api:keyword><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Acetylation</api:keyword><api:keyword scheme="mesh">Genome, Human</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Molecular Sequence Data</api:keyword><api:keyword scheme="mesh">Protein Interaction Domains and Motifs</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>214</api:begin-page><api:end-page>231</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Histone recognition and large-scale structural analysis of the human bromodomain family.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>149</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000302235400022"><api:citation-count>121</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Mangos</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>J-P</api:initials></api:person><api:person><api:last-name>Barsyte-Lovejoy</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Volkmer</api:last-name><api:initials>R</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Pawson</api:last-name><api:initials>T</api:initials><api:identifiers><api:identifier scheme="researcherid">E-4578-2013</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>A-C</api:initials><api:identifiers><api:identifier scheme="researcherid">E-9982-2010</api:identifier></api:identifiers></api:person><api:person><api:last-name>Arrowsmith</api:last-name><api:initials>CH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000302235400022&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2012.02.013</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2012.02.013"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2012.02.013"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">918FT</api:identifier><api:identifier scheme="pubmed">22464331</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CELL</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>214</api:begin-page><api:end-page>231</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>30</api:day><api:month>3</api:month><api:year>2012</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>149</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-84859181036"><api:citation-count>129</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Bromodomains (BRDs) are protein interaction modules that specifically recognize Îµ-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family. Â© 2012 Elsevier Inc.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>panagis.filippakopoulos@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mangos</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Toronto</api:line><api:line type="city">Toronto, ON M5G 1L7</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55158251300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">50262281800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>J-P</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Centre for Systems Biology</api:line><api:line type="organisation">Samuel Lunenfeld Research Institute</api:line><api:line type="street-address">600 University Avenue</api:line><api:line type="city">Toronto, ON M5G 1X5</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35248374900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Barsyte-Lovejoy</api:last-name><api:initials>D</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Toronto</api:line><api:line type="city">Toronto, ON M5G 1L7</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602873877</api:identifier></api:identifiers></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36717516700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Volkmer</api:last-name><api:initials>R</api:initials><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Institut fÃ¼r Medizinische Immunologie</api:line><api:line type="organisation">CharitÃ©-UniversitÃ¤tsmedizin Berlin</api:line><api:line type="street-address">Hessische Str. 3-4</api:line><api:line type="city">10115 Berlin</api:line><api:line type="country">deu</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">16025842200</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Pawson</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Centre for Systems Biology</api:line><api:line type="organisation">Samuel Lunenfeld Research Institute</api:line><api:line type="street-address">600 University Avenue</api:line><api:line type="city">Toronto, ON M5G 1X5</api:line><api:line type="country">can</api:line></api:address><api:address iso-country-code="CA"><api:line type="organisation">Department of Molecular Genetics</api:line><api:line type="organisation">University of Toronto</api:line><api:line type="street-address">1 Kings College Circle</api:line><api:line type="city">Toronto, ON M5S 1A8</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35378370700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>A-C</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Centre for Systems Biology</api:line><api:line type="organisation">Samuel Lunenfeld Research Institute</api:line><api:line type="street-address">600 University Avenue</api:line><api:line type="city">Toronto, ON M5G 1X5</api:line><api:line type="country">can</api:line></api:address><api:address iso-country-code="CA"><api:line type="organisation">Department of Molecular Genetics</api:line><api:line type="organisation">University of Toronto</api:line><api:line type="street-address">1 Kings College Circle</api:line><api:line type="city">Toronto, ON M5S 1A8</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7003712519</api:identifier></api:identifiers></api:person><api:person><api:last-name>Arrowsmith</api:last-name><api:initials>CH</api:initials><api:addresses><api:address iso-country-code="CA"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Toronto</api:line><api:line type="city">Toronto, ON M5G 1L7</api:line><api:line type="country">can</api:line></api:address><api:address iso-country-code="CA"><api:line type="organisation">Department of Medical Biophysics</api:line><api:line type="organisation">Ontario Cancer Institute</api:line><api:line type="organisation">University of Toronto</api:line><api:line type="city">Toronto, ON M5G 1L7</api:line><api:line type="country">can</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006642154</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Department of Oncology</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus Research Building</api:line><api:line type="street-address">Roosevelt Drive</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="US"><api:line type="organisation">Department of Biochemistry and Molecular Biology</api:line><api:line type="organisation">George Washington University</api:line><api:line type="organisation">School of Medicine and Health Sciences</api:line><api:line type="street-address">2300 Eye Street, NW</api:line><api:line type="city">Washington, DC, 20037</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2012.02.013</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2012.02.013"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2012.02.013"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1097-4172</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1097-4172"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">22464331</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>214</api:begin-page><api:end-page>231</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0092867412002139</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>30</api:day><api:month>3</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Histone recognition and large-scale structural analysis of the human bromodomain family</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>149</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1016/j.cell.2012.02.013"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Mangos</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Lambert</api:last-name><api:initials>J-P</api:initials></api:person><api:person><api:last-name>Barsyte-Lovejoy</api:last-name><api:initials>D</api:initials></api:person><api:person><api:last-name>Felletar</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Volkmer</api:last-name><api:initials>R</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Pawson</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Gingras</api:last-name><api:initials>A-C</api:initials></api:person><api:person><api:last-name>Arrowsmith</api:last-name><api:initials>CH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2012.02.013</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2012.02.013"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2012.02.013"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>1</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>214</api:begin-page><api:end-page>231</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>149</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0092-8674" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"><api:records><api:record source-name="era2012"><api:title>Cell</api:title></api:record><api:record source-name="snip"><api:title>Cell</api:title></api:record><api:record source-name="era2010"><api:title>Cell</api:title></api:record><api:record source-name="science-metrix"><api:title>Cell</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Cell</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322665/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521887</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T11:35:44.183+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521887"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/193311"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/193311">Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation.</a></p></div></content><api:relationship id="521887" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521887"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="193311" last-modified-when="2014-10-31T15:50:26.77+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/193311" created-when="2011-10-29T11:23:10.553+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2011-10-19</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="22027370" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The generation of affinity reagents to large numbers of human proteins depends on the ability to express the target proteins as high-quality antigens. The Structural Genomics Consortium (SGC) focuses on the production and structure determination of human proteins. In a 7-year period, the SGC has deposited crystal structures of &gt;800 human protein domains, and has additionally expressed and purified a similar number of protein domains that have not yet been crystallised. The targets include a diversity of protein domains, with an attempt to provide high coverage of protein families. The family approach provides an excellent basis for characterising the selectivity of affinity reagents. We present a summary of the approaches used to generate purified human proteins or protein domains, a test case demonstrating the ability to rapidly generate new proteins, and an optimisation study on the modification of &gt;70 proteins by biotinylation in vivo. These results provide a unique synergy between large-scale structural projects and the recent efforts to produce a wide coverage of affinity reagents to the human proteome.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">The Structural Genomics Consortium, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Cooper</api:last-name><api:initials>CD</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Allerston</api:last-name><api:initials>CK</api:initials></api:person><api:person><api:last-name>Phillips</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>HammarstrÃ¶m</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Daga</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Berridge</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Mahajan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>GrÃ¤slund</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/22027370</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.nbt.2011.10.007</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.nbt.2011.10.007"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.nbt.2011.10.007"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1876-4347</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1876-4347"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3383991</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>N Biotechnol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Biotin</api:keyword><api:keyword scheme="mesh">Biotinylation</api:keyword><api:keyword scheme="mesh">Chromatography, Affinity</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Culture Media</api:keyword><api:keyword scheme="mesh">Genes</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mass Spectrometry</api:keyword><api:keyword scheme="mesh">Plasmids</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Proteome</api:keyword><api:keyword scheme="mesh">Proteomics</api:keyword><api:keyword scheme="mesh">Solubility</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Netherlands</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>515</api:begin-page><api:end-page>525</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S1871-6784(11)00227-5</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>6</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>29</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:22027370"><api:citation-count>2</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The generation of affinity reagents to large numbers of human proteins depends on the ability to express the target proteins as high-quality antigens. The Structural Genomics Consortium (SGC) focuses on the production and structure determination of human proteins. In a 7-year period, the SGC has deposited crystal structures of &gt;800 human protein domains, and has additionally expressed and purified a similar number of protein domains that have not yet been crystallised. The targets include a diversity of protein domains, with an attempt to provide high coverage of protein families. The family approach provides an excellent basis for characterising the selectivity of affinity reagents. We present a summary of the approaches used to generate purified human proteins or protein domains, a test case demonstrating the ability to rapidly generate new proteins, and an optimisation study on the modification of &gt;70 proteins by biotinylation in vivo. These results provide a unique synergy between large-scale structural projects and the recent efforts to produce a wide coverage of affinity reagents to the human proteome.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">The Structural Genomics Consortium, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, United Kingdom.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Cooper</api:last-name><api:initials>CD</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Allerston</api:last-name><api:initials>CK</api:initials></api:person><api:person><api:last-name>Phillips</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>HammarstrÃ¶m</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Daga</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Berridge</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Mahajan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>GrÃ¤slund</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0001-6886-898X</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.nbt.2011.10.007</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.nbt.2011.10.007"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.nbt.2011.10.007"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1876-4347</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1876-4347"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">22027370</api:identifier><api:identifier scheme="pmc">PMC3383991</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1871-6784</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1871-6784"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>New biotechnology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Animals</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Biotin</api:keyword><api:keyword scheme="mesh">Proteome</api:keyword><api:keyword scheme="mesh">Culture Media</api:keyword><api:keyword scheme="mesh">Chromatography, Affinity</api:keyword><api:keyword scheme="mesh">Crystallization</api:keyword><api:keyword scheme="mesh">Biotinylation</api:keyword><api:keyword scheme="mesh">Proteomics</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Genes</api:keyword><api:keyword scheme="mesh">Plasmids</api:keyword><api:keyword scheme="mesh">Solubility</api:keyword><api:keyword scheme="mesh">Mass Spectrometry</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>515</api:begin-page><api:end-page>525</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>29</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000305606500002"><api:citation-count>4</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Cooper</api:last-name><api:initials>CDO</api:initials><api:identifiers><api:identifier scheme="researcherid">E-8392-2013</api:identifier><api:identifier scheme="researcherid">G-9982-2014</api:identifier></api:identifiers></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Allerston</api:last-name><api:initials>CK</api:initials></api:person><api:person><api:last-name>Phillips</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>Hammarstrom</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Daga</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Berridge</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Mahajan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Graslund</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="researcherid">F-1105-2013</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000305606500002&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.nbt.2011.10.007</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.nbt.2011.10.007"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.nbt.2011.10.007"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">963FV</api:identifier><api:identifier scheme="pubmed">22027370</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1871-6784</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1871-6784"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>NEW BIOTECHNOLOGY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>515</api:begin-page><api:end-page>525</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>15</api:day><api:month>6</api:month><api:year>2012</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>29</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-80455123888"><api:citation-count>0</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Cooper</api:last-name><api:initials>CDO</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Allerston</api:last-name><api:initials>CK</api:initials></api:person><api:person><api:last-name>Phillips</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>HammarstrÃ¶m</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Daga</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Berridge</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Mahajan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>GrÃ¤slund</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials></api:person></api:people></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1876-4347</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1876-4347"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1871-6784</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1871-6784"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>New Biotechnology</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1016/j.nbt.2011.10.007"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Keates</api:last-name><api:initials>T</api:initials></api:person><api:person><api:last-name>Cooper</api:last-name><api:initials>CDO</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Allerston</api:last-name><api:initials>CK</api:initials></api:person><api:person><api:last-name>Phillips</api:last-name><api:initials>C</api:initials></api:person><api:person><api:last-name>HammarstrÃ¶m</api:last-name><api:initials>M</api:initials></api:person><api:person><api:last-name>Daga</api:last-name><api:initials>N</api:initials></api:person><api:person><api:last-name>Berridge</api:last-name><api:initials>G</api:initials></api:person><api:person><api:last-name>Mahajan</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>GrÃ¤slund</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.nbt.2011.10.007</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.nbt.2011.10.007"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.nbt.2011.10.007"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1871-6784</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1871-6784"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>5</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>New Biotechnology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>515</api:begin-page><api:end-page>525</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2012</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>29</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1871-6784" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1871-6784"><api:records><api:record source-name="era2012"><api:title>New Biotechnology</api:title></api:record><api:record source-name="snip"><api:title>New Biotechnology</api:title></api:record><api:record source-name="era2010"><api:title>New Biotechnology</api:title></api:record><api:record source-name="science-metrix"><api:title>New Biotechnology</api:title></api:record><api:record source-name="sjr"><api:title>New Biotechnology</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>New Biotechnology</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/193311/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/324915</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T11:35:44.183+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/324915"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322025"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Structural basis of fumarate hydratase deficiency.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322025">Structural basis of fumarate hydratase deficiency.</a></p></div></content><api:relationship id="324915" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/324915"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="322025" last-modified-when="2014-09-02T06:59:08.493+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322025" created-when="2012-04-05T15:12:30.32+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:merge-history><api:merge when="2013-09-11T12:37:19.107+01:00"><api:merged-object id="166730" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/166730"/><api:merged-into-object id="322025" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322025"/></api:merge><api:merge when="2012-04-05T15:13:07.953+01:00"><api:merged-object id="127206" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/127206"/><api:merged-into-object id="166730" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/166730"/></api:merge></api:merge-history><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2011-03-29</api:reporting-date-1><api:records><api:record format="native" source-id="1" source-name="manual" source-display-name="Manual" id-at-source="71C74230-47DE-434C-8ED4-1100561ED4D5" is-preferred-record="true"><api:verification-status>unverified</api:verification-status><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Fumarate hydratase catalyzes the stereospecific hydration across the olefinic double bond in fumarate leading to L-malate. The enzyme is expressed in mitochondrial and cytosolic compartments, and participates in the Krebs cycle in mitochondria, as well as in regulation of cytosolic fumarate levels. Fumarate hydratase deficiency is an autosomal recessive trait presenting as metabolic disorder with severe encephalopathy, seizures and poor neurological outcome. Heterozygous mutations are associated with a predisposition to cutaneous and uterine leiomyomas and to renal cancer. The crystal structure of human fumarate hydratase shows that mutations can be grouped into two distinct classes either affecting structural integrity of the core enzyme architecture, or are localized around the enzyme active site. An interactive version of this manuscript (which may contain additional mutations appended after acceptance of this manuscript) may be found on the SSIEM website at: http://www.ssiem.org/resources/structures/FH .</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="street-address">Structural Genomics Consortium, University of Oxford, Old Road Campus, Headington OX3 7DQ, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1007/s10545-011-9294-8</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1007/s10545-011-9294-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1007/s10545-011-9294-8"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-2665</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1573-2665"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Inherit Metab Dis</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Catalytic Domain</api:keyword><api:keyword>Crystallography, X-Ray</api:keyword><api:keyword>Fumarate Hydratase</api:keyword><api:keyword>Humans</api:keyword><api:keyword>Metabolism, Inborn Errors</api:keyword><api:keyword>Mitochondrial Diseases</api:keyword><api:keyword>Models, Molecular</api:keyword><api:keyword>Mutant Proteins</api:keyword><api:keyword>Mutation</api:keyword><api:keyword>Protein Conformation</api:keyword><api:keyword>Protein Folding</api:keyword><api:keyword>Structure-Activity Relationship</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Netherlands</api:text></api:field><api:field name="notes" type="text" display-name="Notes"><api:text>PMCID: PMC3109261</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>671</api:begin-page><api:end-page>676</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structural basis of fumarate hydratase deficiency.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item><api:item>Letter</api:item><api:item>Review</api:item><api:item>Editorial Comment</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>34</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:21445611"><api:citation-count>7</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Fumarate hydratase catalyzes the stereospecific hydration across the olefinic double bond in fumarate leading to L-malate. The enzyme is expressed in mitochondrial and cytosolic compartments, and participates in the Krebs cycle in mitochondria, as well as in regulation of cytosolic fumarate levels. Fumarate hydratase deficiency is an autosomal recessive trait presenting as metabolic disorder with severe encephalopathy, seizures and poor neurological outcome. Heterozygous mutations are associated with a predisposition to cutaneous and uterine leiomyomas and to renal cancer. The crystal structure of human fumarate hydratase shows that mutations can be grouped into two distinct classes either affecting structural integrity of the core enzyme architecture, or are localized around the enzyme active site. An interactive version of this manuscript (which may contain additional mutations appended after acceptance of this manuscript) may be found on the SSIEM website at: http://www.ssiem.org/resources/structures/FH .</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, University of Oxford, Old Road Campus, Headington OX3 7DQ, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Kavanagh</api:last-name><api:initials>KL</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3934" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3934"/></api:links><api:last-name>Yue</api:last-name><api:initials>WW</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0001-6886-898X</api:identifier></api:identifiers></api:person><api:person><api:last-name>Sacchettini</api:last-name><api:initials>J</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1251" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1251"/></api:links><api:last-name>Oppermann</api:last-name><api:initials>U</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1007/s10545-011-9294-8</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1007/s10545-011-9294-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1007/s10545-011-9294-8"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-2665</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1573-2665"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">21445611</api:identifier><api:identifier scheme="pmc">PMC3109261</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0141-8955</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0141-8955"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of inherited metabolic disease</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Metabolism, Inborn Errors</api:keyword><api:keyword scheme="mesh">Mitochondrial Diseases</api:keyword><api:keyword scheme="mesh">Fumarate Hydratase</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Catalytic Domain</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Protein Folding</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Mutant Proteins</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>671</api:begin-page><api:end-page>676</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structural basis of fumarate hydratase deficiency.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>34</api:text></api:field><api:files><api:file proprietary-id="http://europepmc.org/articles/PMC3109261?pdf=render"><api:file-url>http://europepmc.org/articles/PMC3109261?pdf=render</api:file-url><api:extension>pdf</api:extension></api:file></api:files></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="21445611"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Fumarate hydratase catalyzes the stereospecific hydration across the olefinic double bond in fumarate leading to L-malate. The enzyme is expressed in mitochondrial and cytosolic compartments, and participates in the Krebs cycle in mitochondria, as well as in regulation of cytosolic fumarate levels. Fumarate hydratase deficiency is an autosomal recessive trait presenting as metabolic disorder with severe encephalopathy, seizures and poor neurological outcome. Heterozygous mutations are associated with a predisposition to cutaneous and uterine leiomyomas and to renal cancer. The crystal structure of human fumarate hydratase shows that mutations can be grouped into two distinct classes either affecting structural integrity of the core enzyme architecture, or are localized around the enzyme active site. An interactive version of this manuscript (which may contain additional mutations appended after acceptance of this manuscript) may be found on the SSIEM website at: http://www.ssiem.org/resources/structures/FH .</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, University of Oxford, Old Road Campus, Headington OX3 7DQ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Kavanagh</api:last-name><api:initials>KL</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3934" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3934"/></api:links><api:last-name>Yue</api:last-name><api:initials>WW</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Sacchettini</api:last-name><api:initials>J</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1251" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1251"/></api:links><api:last-name>Oppermann</api:last-name><api:initials>U</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/21445611</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1007/s10545-011-9294-8</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1007/s10545-011-9294-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1007/s10545-011-9294-8"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-2665</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1573-2665"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC3109261</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>J Inherit Metab Dis</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Catalytic Domain</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Fumarate Hydratase</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Metabolism, Inborn Errors</api:keyword><api:keyword scheme="mesh">Mitochondrial Diseases</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Mutant Proteins</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Protein Folding</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>Netherlands</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>671</api:begin-page><api:end-page>676</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structural basis of fumarate hydratase deficiency.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>34</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000291360100015"><api:citation-count>9</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Kavanagh</api:last-name><api:initials>KL</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3934" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3934"/></api:links><api:last-name>Yue</api:last-name><api:initials>WW</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials><api:identifiers><api:identifier scheme="researcherid">G-1250-2013</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="researcherid">F-1105-2013</api:identifier></api:identifiers></api:person><api:person><api:last-name>Sacchettini</api:last-name><api:initials>J</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1251" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1251"/></api:links><api:last-name>Oppermann</api:last-name><api:initials>U</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000291360100015&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1007/s10545-011-9294-8</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1007/s10545-011-9294-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1007/s10545-011-9294-8"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">774CY</api:identifier><api:identifier scheme="pubmed">21445611</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0141-8955</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0141-8955"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>JOURNAL OF INHERITED METABOLIC DISEASE</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>671</api:begin-page><api:end-page>676</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2011</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structural basis of fumarate hydratase deficiency</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>34</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-79959791716"><api:citation-count>12</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Fumarate hydratase catalyzes the stereospecific hydration across the olefinic double bond in fumarate leading to L-malate. The enzyme is expressed in mitochondrial and cytosolic compartments, and participates in the Krebs cycle in mitochondria, as well as in regulation of cytosolic fumarate levels. Fumarate hydratase deficiency is an autosomal recessive trait presenting as metabolic disorder with severe encephalopathy, seizures and poor neurological outcome. Heterozygous mutations are associated with a predisposition to cutaneous and uterine leiomyomas and to renal cancer. The crystal structure of human fumarate hydratase shows that mutations can be grouped into two distinct classes either affecting structural integrity of the core enzyme architecture, or are localized around the enzyme active site. Â© 2011 The Author(s).</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35741715400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kavanagh</api:last-name><api:initials>KL</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35427571800</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="3934" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3934"/></api:links><api:last-name>Yue</api:last-name><api:initials>WW</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7102549319</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">16042341700</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">37050100200</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">55991671200</api:identifier></api:identifiers></api:person><api:person><api:last-name>Sacchettini</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Department of Biochemistry and Biophysics</api:line><api:line type="organisation">Texas A and M University</api:line><api:line type="city">College Station, TX 77843-2128</api:line><api:line type="country">usa</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006739881</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1251" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1251"/></api:links><api:last-name>Oppermann</api:last-name><api:initials>U</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Old Road Campus</api:line><api:line type="city">Headington OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Botnar Research Center</api:line><api:line type="organisation">NIHR Oxford Biomedical Research Unit</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>udo.oppermann@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7006473645</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1007/s10545-011-9294-8</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1007/s10545-011-9294-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1007/s10545-011-9294-8"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-2665</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1573-2665"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">21445611</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0141-8955</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0141-8955"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Inherited Metabolic Disease</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>671</api:begin-page><api:end-page>676</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structural basis of fumarate hydratase deficiency</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>34</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-79952990002"><api:citation-count>0</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Kavanagh</api:last-name><api:initials>KL</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3934" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3934"/></api:links><api:last-name>Yue</api:last-name><api:initials>WW</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Sacchettini</api:last-name><api:initials>J</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1251" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1251"/></api:links><api:last-name>Oppermann</api:last-name><api:initials>U</api:initials></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1573-2665</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1573-2665"/></api:links></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Inherited Metabolic Disease</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1</api:begin-page><api:end-page>6</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Structural basis of fumarate hydratase deficiency</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1007/s10545-011-9294-8"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Picaud</api:last-name><api:initials>S</api:initials></api:person><api:person><api:last-name>Kavanagh</api:last-name><api:initials>KL</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="3934" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/3934"/></api:links><api:last-name>Yue</api:last-name><api:initials>WW</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4063" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/></api:links><api:last-name>Muller-Knapp</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="606" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/606"/></api:links><api:last-name>Gileadi</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>Sacchettini</api:last-name><api:initials>J</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="1251" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/1251"/></api:links><api:last-name>Oppermann</api:last-name><api:initials>U</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1007/s10545-011-9294-8</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1007/s10545-011-9294-8"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1007/s10545-011-9294-8"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1573-2665</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1573-2665"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0141-8955</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0141-8955"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Journal of Inherited Metabolic Disease</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>671</api:begin-page><api:end-page>676</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2011</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Structural basis of fumarate hydratase deficiency</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>34</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0141-8955" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0141-8955"><api:records><api:record source-name="era2012"><api:title>Journal of Inherited Metabolic Disease</api:title></api:record><api:record source-name="snip"><api:title>Journal of Inherited Metabolic Disease</api:title></api:record><api:record source-name="era2010"><api:title>Journal of Inherited Metabolic Disease</api:title></api:record><api:record source-name="science-metrix"><api:title>Journal of Inherited Metabolic Disease</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Journal of Inherited Metabolic Disease</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/322025/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521888</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T12:13:16.78+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521888"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/90339"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Targeting kinases for the treatment of inflammatory diseases.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/90339">Targeting kinases for the treatment of inflammatory diseases.</a></p></div></content><api:relationship id="521888" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521888"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>true</api:is-favourite><api:related direction="from"><api:object category="publication" id="90339" last-modified-when="2014-09-14T01:39:43.253+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/90339" created-when="2010-10-16T04:15:41.157+01:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2010-09-01</api:reporting-date-1><api:records><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-77955945487" is-preferred-record="true"><api:citation-count>8</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Importance of the field: Inflammatory diseases are one of the major health issues and have become a major focus in the pharmaceutical and biotech industries. To date, drugs prescribed for treatment of these diseases target enzymes that are not specific to the immune system resulting in adverse effects. The main challenge of this research field is, therefore, identifying targets that act specifically on the diseased tissue. Areas covered in this review: This review summarizes drug discovery efforts on kinases that have been identified as key players mediating inflammation and autoimmune disorders. In particular, we discuss recent developments on well-established targets such as mammalian target of rapamycin, JAK3, spleen tyrosine kinase, p38Î± and lymphocyte specific kinase but provide also a perspective on emerging targets. What the reader will gain: The reader will obtain an overview of drug discovery efforts on kinases in inflammation, recent clinical and preclinical data and developed inhibitor scaffolds. In addition, the reader will be updated on issues in target validation of current drug targets and the potential of selected novel kinase targets in this important disease area. Take home message: Cellular signaling networks that regulate inflammatory response are still poorly understood making rational selection of targets challenging. Recent data suggest that kinase targets that are specific to the immune system and mediate signals immediately downstream of surface receptors are most efficacious in the clinic. Â© 2010 Informa UK, Ltd.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium (SGC)</api:line><api:line type="organisation">Department of Clinical Medicine</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium (SGC)</api:line><api:line type="organisation">Department of Clinical Medicine</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Department of Clinical Pharmacology</api:line><api:line type="organisation">Old Road Campus Research Building</api:line><api:line type="city">Oxford OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1517/17460441.2010.504203</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1517/17460441.2010.504203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1517/17460441.2010.504203"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1746-0441</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-0441"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Expert Opinion on Drug Discovery</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Emerging targets</api:keyword><api:keyword>IKK</api:keyword><api:keyword>Inflammation</api:keyword><api:keyword>JAK3LCK</api:keyword><api:keyword>MTOR</api:keyword><api:keyword>P38Î±</api:keyword><api:keyword>Protein kinases</api:keyword><api:keyword>SYK</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>867</api:begin-page><api:end-page>881</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Targeting kinases for the treatment of inflammatory diseases</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:22823261"><api:citation-count>4</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>IMPORTANCE OF THE FIELD: Inflammatory diseases are one of the major health issues and have become a major focus in the pharmaceutical and biotech industries. To date, drugs prescribed for treatment of these diseases target enzymes that are not specific to the immune system resulting in adverse effects. The main challenge of this research field is, therefore, identifying targets that act specifically on the diseased tissue. AREAS COVERED IN THIS REVIEW: This review summarizes drug discovery efforts on kinases that have been identified as key players mediating inflammation and autoimmune disorders. In particular, we discuss recent developments on well-established targets such as mammalian target of rapamycin, JAK3, spleen tyrosine kinase, p38Î± and lymphocyte specific kinase but provide also a perspective on emerging targets. WHAT THE READER WILL GAIN: The reader will obtain an overview of drug discovery efforts on kinases in inflammation, recent clinical and preclinical data and developed inhibitor scaffolds. In addition, the reader will be updated on issues in target validation of current drug targets and the potential of selected novel kinase targets in this important disease area. TAKE HOME MESSAGE: Cellular signaling networks that regulate inflammatory response are still poorly understood making rational selection of targets challenging. Recent data suggest that kinase targets that are specific to the immune system and mediate signals immediately downstream of surface receptors are most efficacious in the clinic.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">University of Oxford, Structural Genomics Consortium (SGC), Department of Clinical Medicine, Old Road Campus Research Building, Oxford OX3 7DQ, UK  + 44 1865 617584 ;  + 44 1865 617575 ;  stefan.knapp@sgc.ox.ac.uk.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1517/17460441.2010.504203</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1517/17460441.2010.504203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1517/17460441.2010.504203"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1746-045X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-045X"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">22823261</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1746-0441</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-0441"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Expert opinion on drug discovery</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>867</api:begin-page><api:end-page>881</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Targeting kinases for the treatment of inflammatory diseases.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="22823261"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Inflammatory diseases are one of the major health issues and have become a major focus in the pharmaceutical and biotech industries. To date, drugs prescribed for treatment of these diseases target enzymes that are not specific to the immune system resulting in adverse effects. The main challenge of this research field is, therefore, identifying targets that act specifically on the diseased tissue.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">University of Oxford, Structural Genomics Consortium (SGC), Department of Clinical Medicine, Old Road Campus Research Building, Oxford OX3 7DQ, UK + 44 1865 617584 ; + 44 1865 617575 ; stefan.knapp@sgc.ox.ac.uk.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/22823261</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1517/17460441.2010.504203</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1517/17460441.2010.504203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1517/17460441.2010.504203"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1746-045X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-045X"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Expert Opin Drug Discov</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>867</api:begin-page><api:end-page>881</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Targeting kinases for the treatment of inflammatory diseases.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000282292700006"><api:citation-count>10</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000282292700006&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1517/17460441.2010.504203</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1517/17460441.2010.504203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1517/17460441.2010.504203"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">655YO</api:identifier><api:identifier scheme="pubmed">22823261</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1746-0441</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-0441"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>EXPERT OPINION ON DRUG DISCOVERY</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>emerging targets</api:keyword><api:keyword>IKK</api:keyword><api:keyword>inflammation</api:keyword><api:keyword>JAK3LCK</api:keyword><api:keyword>mTOR</api:keyword><api:keyword>p38 alpha</api:keyword><api:keyword>protein kinases</api:keyword><api:keyword>SYK</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>867</api:begin-page><api:end-page>881</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2010</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Targeting kinases for the treatment of inflammatory diseases</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1517/17460441.2010.504203"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1517/17460441.2010.504203</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1517/17460441.2010.504203"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1517/17460441.2010.504203"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1746-045X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-045X"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1746-0441</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-0441"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Expert Opinion on Drug Discovery</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>867</api:begin-page><api:end-page>881</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>9</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Targeting kinases for the treatment of inflammatory diseases</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>5</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1746-0441" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1746-0441"><api:records><api:record source-name="snip"><api:title>Expert Opinion on Drug Discovery</api:title></api:record><api:record source-name="science-metrix"><api:title>Expert Opinion on Drug Discovery</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Expert Opinion on Drug Discovery</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/90339/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521893</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2014-01-10T17:16:20.203+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521893"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/48931"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: The (un)targeted cancer kinome.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/48931">The (un)targeted cancer kinome.</a></p></div></content><api:relationship id="521893" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521893"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="48931" last-modified-when="2014-11-02T01:39:34.763+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/48931" created-when="2010-03-02T02:11:48.01+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2010-03-01</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="20154661" is-preferred-record="true"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Oleg Fedorov, Susanne MÃ¼ller and Stefan Knapp are in the Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/20154661</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.297</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.297"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.297"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nat Chem Biol</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>ENG</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>166</api:begin-page><api:end-page>169</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>nchembio.297</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The (un)targeted cancer kinome.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>JOURNAL ARTICLE</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>6</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:20154661"><api:citation-count>26</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text></api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Oleg Fedorov, Susanne MÃ¼ller and Stefan Knapp are in the Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Oxford, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0001-9004-1815</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.297</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.297"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.297"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">20154661</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature chemical biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>166</api:begin-page><api:end-page>169</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The (un)targeted cancer kinome.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>6</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000274565100004"><api:citation-count>69</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="researcherid">B-6412-2014</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000274565100004&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">556CK</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>NATURE CHEMICAL BIOLOGY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>166</api:begin-page><api:end-page>169</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The (un)targeted cancer kinome</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>6</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-77249164281"><api:citation-count>78</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Nuffield Department of Clinical Medicine, Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Department of Clinical Pharmacology</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.297</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.297"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.297"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1552-4469</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4469"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature Chemical Biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>166</api:begin-page><api:end-page>169</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>NCHEMBIO297</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The (un)targeted cancer kinome</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Note</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>6</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1038/nchembio.297"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/nchembio.297</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1038/nchembio.297"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/nchembio.297"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1548-7105</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1548-7105"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>1552-4450</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>3</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Nature Chemical Biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>166</api:begin-page><api:end-page>169</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>3</api:month><api:year>2010</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
The (un)targeted cancer kinome</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>6</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="1552-4450" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1552-4450"><api:records><api:record source-name="era2012"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="snip"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="era2010"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="science-metrix"><api:title>Nature Chemical Biology</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Nature Chemical Biology</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/48931/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521889</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T11:35:44.183+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521889"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34981"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: SH2 domains: modulators of nonreceptor tyrosine kinase activity.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34981">SH2 domains: modulators of nonreceptor tyrosine kinase activity.</a></p></div></content><api:relationship id="521889" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521889"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="34981" last-modified-when="2014-11-07T18:12:57.123+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34981" created-when="2010-01-11T16:22:28.603+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-12-01</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="19926274" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The Src homology 2 (SH2) domain is a sequence-specific phosphotyrosine-binding module present in many signaling molecules. In cytoplasmic tyrosine kinases, the SH2 domain is located N-terminally to the catalytic kinase domain (SH1) where it mediates cellular localization, substrate recruitment, and regulation of kinase activity. Initially, structural studies established a role of the SH2 domain stabilizing the inactive state of Src family members. However, biochemical characterization showed that the presence of the SH2 domain is frequently required for catalytic activity, suggesting a crucial function stabilizing the active state of many nonreceptor tyrosine kinases. Recently, the structure of the SH2-kinase domain of Fes revealed that the SH2 domain stabilizes the active kinase conformation by direct interactions with the regulatory helix alphaC. Stabilizing interactions between the SH2 and the kinase domains have also been observed in the structures of active Csk and Abl. Interestingly, mutations in the SH2 domain found in human disease can be explained by SH2 domain destabilization or incorrect positioning of the SH2. Here we summarize our understanding of mechanisms that lead to tyrosine kinase activation by direct interactions mediated by the SH2 domain and discuss how mutations in the SH2 domain trigger kinase inactivation.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford OX3 7DQ, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/19926274</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.sbi.2009.10.001</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.sbi.2009.10.001"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.sbi.2009.10.001"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1879-033X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1879-033X"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2791838</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Curr Opin Struct Biol</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Disease</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">Enzyme Stability</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Protein-Tyrosine Kinases</api:keyword><api:keyword scheme="mesh">src Homology Domains</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>643</api:begin-page><api:end-page>649</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0959-440X(09)00151-1</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>SH2 domains: modulators of nonreceptor tyrosine kinase activity.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Review</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:19926274"><api:citation-count>25</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The Src homology 2 (SH2) domain is a sequence-specific phosphotyrosine-binding module present in many signaling molecules. In cytoplasmic tyrosine kinases, the SH2 domain is located N-terminally to the catalytic kinase domain (SH1) where it mediates cellular localization, substrate recruitment, and regulation of kinase activity. Initially, structural studies established a role of the SH2 domain stabilizing the inactive state of Src family members. However, biochemical characterization showed that the presence of the SH2 domain is frequently required for catalytic activity, suggesting a crucial function stabilizing the active state of many nonreceptor tyrosine kinases. Recently, the structure of the SH2-kinase domain of Fes revealed that the SH2 domain stabilizes the active kinase conformation by direct interactions with the regulatory helix alphaC. Stabilizing interactions between the SH2 and the kinase domains have also been observed in the structures of active Csk and Abl. Interestingly, mutations in the SH2 domain found in human disease can be explained by SH2 domain destabilization or incorrect positioning of the SH2. Here we summarize our understanding of mechanisms that lead to tyrosine kinase activation by direct interactions mediated by the SH2 domain and discuss how mutations in the SH2 domain trigger kinase inactivation.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford OX3 7DQ, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.sbi.2009.10.001</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.sbi.2009.10.001"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.sbi.2009.10.001"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1879-033X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1879-033X"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">19926274</api:identifier><api:identifier scheme="pmc">PMC2791838</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-440X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0959-440X"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Current opinion in structural biology</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Disease</api:keyword><api:keyword scheme="mesh">Enzyme Stability</api:keyword><api:keyword scheme="mesh">Enzyme Activation</api:keyword><api:keyword scheme="mesh">src Homology Domains</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Protein-Tyrosine Kinases</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>643</api:begin-page><api:end-page>649</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>SH2 domains: modulators of nonreceptor tyrosine kinase activity.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Review</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000272936300002"><api:citation-count>29</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000272936300002&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.sbi.2009.10.001</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.sbi.2009.10.001"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.sbi.2009.10.001"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">534ZM</api:identifier><api:identifier scheme="pubmed">19926274</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-440X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0959-440X"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CURRENT OPINION IN STRUCTURAL BIOLOGY</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>643</api:begin-page><api:end-page>649</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2009</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>SH2 domains: modulators of nonreceptor tyrosine kinase activity</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-70649096122"><api:citation-count>31</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>The Src homology 2 (SH2) domain is a sequence-specific phosphotyrosine-binding module present in many signaling molecules. In cytoplasmic tyrosine kinases, the SH2 domain is located N-terminally to the catalytic kinase domain (SH1) where it mediates cellular localization, substrate recruitment, and regulation of kinase activity. Initially, structural studies established a role of the SH2 domain stabilizing the inactive state of Src family members. However, biochemical characterization showed that the presence of the SH2 domain is frequently required for catalytic activity, suggesting a crucial function stabilizing the active state of many nonreceptor tyrosine kinases. Recently, the structure of the SH2-kinase domain of Fes revealed that the SH2 domain stabilizes the active kinase conformation by direct interactions with the regulatory helix Î±C. Stabilizing interactions between the SH2 and the kinase domains have also been observed in the structures of active Csk and Abl. Interestingly, mutations in the SH2 domain found in human disease can be explained by SH2 domain destabilization or incorrect positioning of the SH2. Here we summarize our understanding of mechanisms that lead to tyrosine kinase activation by direct interactions mediated by the SH2 domain and discuss how mutations in the SH2 domain trigger kinase inactivation. Â© 2009 Elsevier Ltd. All rights reserved.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive, Headington</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive, Headington</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive, Headington</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Department of Clinical Pharmacology</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Roosevelt Drive, Headington</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.sbi.2009.10.001</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.sbi.2009.10.001"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.sbi.2009.10.001"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">19926274</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-440X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0959-440X"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Current Opinion in Structural Biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>643</api:begin-page><api:end-page>649</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0959440X09001511</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>SH2 domains: modulators of nonreceptor tyrosine kinase activity</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Review</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1016/j.sbi.2009.10.001"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.sbi.2009.10.001</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.sbi.2009.10.001"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.sbi.2009.10.001"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0959-440X</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0959-440X"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Current Opinion in Structural Biology</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>643</api:begin-page><api:end-page>649</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
SH2 domains: modulators of nonreceptor tyrosine kinase activity</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>19</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0959-440X" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0959-440X"><api:records><api:record source-name="era2012"><api:title>Current Opinion in Structural Biology</api:title></api:record><api:record source-name="snip"><api:title>Current Opinion in Structural Biology</api:title></api:record><api:record source-name="era2010"><api:title>Current Opinion in Structural Biology</api:title></api:record><api:record source-name="science-metrix"><api:title>Current Opinion in Structural Biology</api:title></api:record><api:record source-name="sjr"><api:title>Current Opinion in Structural Biology</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Current Opinion in Structural Biology</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34981/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521911</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T11:35:44.183+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521911"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/41353"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Out of the box binding determines specificity of SH2 domain interaction.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/41353">Out of the box binding determines specificity of SH2 domain interaction.</a></p></div></content><api:relationship id="521911" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521911"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="41353" last-modified-when="2014-09-05T02:41:05.73+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/41353" created-when="2010-01-11T17:19:57.33+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-08-12</api:reporting-date-1><api:records><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-68249083097" is-preferred-record="true"><api:citation-count>1</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>SH2 domains are phosphotyrosine specific interaction modules with largely overlapping sequence specificities. A recent structure by Bae etÂ al. revealed that SH2 domain specificity can be mediated by secondary binding sites located outside the phosphotyrosine binding pocket. Â© 2009 Elsevier Ltd. All rights reserved.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Department of Clinical Pharmacology</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.str.2009.07.002</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.str.2009.07.002"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.str.2009.07.002"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">19679083</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0969-2126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0969-2126"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Structure</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1040</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0969212609002597</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>12</api:day><api:month>8</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Out of the Box Binding Determines Specificity of SH2 Domain Interaction</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Short Survey</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:19679083"><api:citation-count>1</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>SH2 domains are phosphotyrosine specific interaction modules with largely overlapping sequence specificities. A recent structure by Bae et al. revealed that SH2 domain specificity can be mediated by secondary binding sites located outside the phosphotyrosine binding pocket.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.str.2009.07.002</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.str.2009.07.002"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.str.2009.07.002"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1878-4186</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1878-4186"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">19679083</api:identifier><api:identifier scheme="pmc">PMC2741584</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0969-2126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0969-2126"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Structure (London, England : 1993)</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Phosphotyrosine</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">Binding Sites</api:keyword><api:keyword scheme="mesh">src Homology Domains</api:keyword><api:keyword scheme="mesh">Protein Binding</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1040</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Out of the box binding determines specificity of SH2 domain interaction.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>News</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="19679083"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>SH2 domains are phosphotyrosine specific interaction modules with largely overlapping sequence specificities. A recent structure by Bae et al. revealed that SH2 domain specificity can be mediated by secondary binding sites located outside the phosphotyrosine binding pocket.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/19679083</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.str.2009.07.002</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.str.2009.07.002"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.str.2009.07.002"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1878-4186</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1878-4186"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2741584</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Structure</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Binding Sites</api:keyword><api:keyword scheme="mesh">Mutation</api:keyword><api:keyword scheme="mesh">Phosphotyrosine</api:keyword><api:keyword scheme="mesh">Protein Binding</api:keyword><api:keyword scheme="mesh">Signal Transduction</api:keyword><api:keyword scheme="mesh">src Homology Domains</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1040</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0969-2126(09)00259-7</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>12</api:day><api:month>8</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Out of the box binding determines specificity of SH2 domain interaction.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>News</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000269229100004"><api:citation-count>1</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000269229100004&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.str.2009.07.002</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.str.2009.07.002"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.str.2009.07.002"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">486VR</api:identifier><api:identifier scheme="pubmed">19679083</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0969-2126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0969-2126"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>STRUCTURE</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1040</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>12</api:day><api:month>8</api:month><api:year>2009</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Out of the Box Binding Determines Specificity of SH2 Domain Interaction</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1016/j.str.2009.07.002"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.str.2009.07.002</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.str.2009.07.002"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.str.2009.07.002"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0969-2126</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0969-2126"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>8</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Structure</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1040</api:begin-page><api:end-page>1041</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Out of the Box Binding Determines Specificity of SH2 Domain Interaction</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0969-2126" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0969-2126"><api:records><api:record source-name="era2012"><api:title>Structure</api:title></api:record><api:record source-name="snip"><api:title>Structure with Folding &amp; design</api:title></api:record><api:record source-name="era2010"><api:title>Structure</api:title></api:record><api:record source-name="science-metrix"><api:title>Structure</api:title></api:record><api:record source-name="sjr"><api:title>Structure</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Structure</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/41353/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521894</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T12:13:38.157+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521894"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/20499"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: Large-scale structural analysis of the classical human protein tyrosine phosphatome.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/20499">Large-scale structural analysis of the classical human protein tyrosine phosphatome.</a></p></div></content><api:relationship id="521894" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521894"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>true</api:is-favourite><api:related direction="from"><api:object category="publication" id="20499" last-modified-when="2014-10-11T13:12:56.62+01:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/20499" created-when="2009-02-01T01:13:29.673+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2009-01-23</api:reporting-date-1><api:repository-items><api:repository-item repository-id="1" repository-name="ORA"><api:content-file-count>0</api:content-file-count><api:licence-file-count>0</api:licence-file-count><api:status>unknown</api:status><api:repository-files/></api:repository-item></api:repository-items><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="19167335" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-to-toe" dimerization model for RPTPgamma/zeta that is distinct from the "inhibitory wedge" model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Barr</api:last-name><api:initials>AJ</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">University of Oxford, Structural Genomics Consortium, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK. alastair.barr@sgc.ox.ac.uk</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Ugochukwu</api:last-name><api:initials>E</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:last-name>King</api:last-name><api:initials>ON</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Alfano</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/19167335</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2008.11.038</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2008.11.038"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2008.11.038"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1097-4172</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1097-4172"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2638020</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Dimerization</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Protein Tyrosine Phosphatases</api:keyword><api:keyword scheme="mesh">Sequence Alignment</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>352</api:begin-page><api:end-page>363</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0092-8674(08)01513-4</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Large-scale structural analysis of the classical human protein tyrosine phosphatome.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:19167335"><api:citation-count>112</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-to-toe" dimerization model for RPTPgamma/zeta that is distinct from the "inhibitory wedge" model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">University of Oxford, Structural Genomics Consortium, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK. alastair.barr@sgc.ox.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Barr</api:last-name><api:initials>AJ</api:initials></api:person><api:person><api:last-name>Ugochukwu</api:last-name><api:initials>E</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:last-name>King</api:last-name><api:initials>ON</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Alfano</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2008.11.038</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2008.11.038"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2008.11.038"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1097-4172</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1097-4172"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">19167335</api:identifier><api:identifier scheme="pmc">PMC2638020</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Crystallography, X-Ray</api:keyword><api:keyword scheme="mesh">Sequence Alignment</api:keyword><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Protein Structure, Tertiary</api:keyword><api:keyword scheme="mesh">Structure-Activity Relationship</api:keyword><api:keyword scheme="mesh">Dimerization</api:keyword><api:keyword scheme="mesh">Models, Molecular</api:keyword><api:keyword scheme="mesh">Protein Tyrosine Phosphatases</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>352</api:begin-page><api:end-page>363</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Large-scale structural analysis of the classical human protein tyrosine phosphatome.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000262648800022"><api:citation-count>148</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Barr</api:last-name><api:initials>AJ</api:initials></api:person><api:person><api:last-name>Ugochukwu</api:last-name><api:initials>E</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials><api:identifiers><api:identifier scheme="researcherid">G-1250-2013</api:identifier></api:identifiers></api:person><api:person><api:last-name>King</api:last-name><api:initials>ONF</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Alfano</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000262648800022&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2008.11.038</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2008.11.038"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2008.11.038"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">397FR</api:identifier><api:identifier scheme="pubmed">19167335</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CELL</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>352</api:begin-page><api:end-page>363</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-58249138122"><api:citation-count>149</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-to-toe" dimerization model for RPTPÎ³/Î¶ that is distinct from the "inhibitory wedge" model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association. Â© 2009 Elsevier Inc. All rights reserved.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Barr</api:last-name><api:initials>AJ</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>alastair.barr@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7102666001</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ugochukwu</api:last-name><api:initials>E</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">17344435300</api:identifier></api:identifiers></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">16042341700</api:identifier></api:identifiers></api:person><api:person><api:last-name>King</api:last-name><api:initials>ONF</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">16637184600</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">15839490800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Alfano</api:last-name><api:initials>I</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">16315069600</api:identifier></api:identifiers></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602850470</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">23479262400</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="street-address">Old Rd. Campus Research Building, Roosevelt Drive</api:line><api:line type="city">Headington, Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">University of Oxford</api:line><api:line type="organisation">Department of Clinical Pharmacology</api:line><api:line type="street-address">Old Road Campus, Roosevelt Drive</api:line><api:line type="city">Oxford, OX3 7DQ</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2008.11.038</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2008.11.038"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2008.11.038"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">19167335</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>PROTEINS</api:keyword><api:keyword>SIGNALING</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>352</api:begin-page><api:end-page>363</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0092867408015134</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>23</api:day><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1016/j.cell.2008.11.038"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Barr</api:last-name><api:initials>AJ</api:initials></api:person><api:person><api:last-name>Ugochukwu</api:last-name><api:initials>E</api:initials></api:person><api:person><api:last-name>Lee</api:last-name><api:initials>WH</api:initials></api:person><api:person><api:last-name>King</api:last-name><api:initials>ONF</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="2644" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/2644"/></api:links><api:last-name>Filippakopoulos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Alfano</api:last-name><api:initials>I</api:initials></api:person><api:person><api:last-name>Savitsky</api:last-name><api:initials>P</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="4019" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4019"/></api:links><api:last-name>Burgess-Brown</api:last-name><api:initials>NA</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/j.cell.2008.11.038</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1016/j.cell.2008.11.038"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/j.cell.2008.11.038"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0092-8674</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>2</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Cell</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>352</api:begin-page><api:end-page>363</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>1</api:month><api:year>2009</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>136</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0092-8674" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0092-8674"><api:records><api:record source-name="era2012"><api:title>Cell</api:title></api:record><api:record source-name="snip"><api:title>Cell</api:title></api:record><api:record source-name="era2010"><api:title>Cell</api:title></api:record><api:record source-name="science-metrix"><api:title>Cell</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Cell</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/20499/relationships"/></api:object></api:related></api:relationship></entry><entry><id>tag:elements@oxford,4.10:/elements-api/v4.9/relationships/521890</id><category scheme="http://www.symplectic.co.uk/publications/atom/entries/" term="relationship" label="Relationship"/><updated>2013-01-25T11:35:44.183+00:00</updated><link type="application/atom+xml" rel="alternate" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521890"/><link type="application/atom+xml" rel="related" title="Object 1" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34076"/><link type="application/atom+xml" rel="related" title="Object 2" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/4063"/><title>Author of: A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.</title><content type="xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Involving <a href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34076">A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.</a></p></div></content><api:relationship id="521890" type-id="8" type="publication-user-authorship" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/relationships/521890"><!--Relationship type 8 means "Author of" in this context.--><api:is-visible>true</api:is-visible><api:is-favourite>false</api:is-favourite><api:related direction="from"><api:object category="publication" id="34076" last-modified-when="2014-11-01T03:26:04.497+00:00" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34076" created-when="2010-01-11T16:21:07.64+00:00" type-id="5" type="journal-article"><!--Publication type 5 is "journal article"--><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2007-12-18</api:reporting-date-1><api:records><api:record format="native" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="18077363" is-preferred-record="true"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In addition, kinase inhibitors are widely used as specific probes to study cell signaling, but systematic studies describing selectivity of these reagents across a panel of diverse kinases are largely lacking. Here we evaluated the specificity of 156 validated kinase inhibitors, including inhibitors used in clinical trials, against 60 human Ser/Thr kinases using a thermal stability shift assay. Our analysis revealed many unexpected cross-reactivities for inhibitors thought to be specific for certain targets. We also found that certain combinations of active-site residues in the ATP-binding site correlated with the detected ligand promiscuity and that some kinases are highly sensitive to inhibition using diverse chemotypes, suggesting them as preferred intervention points. Our results uncovered also inhibitor cross-reactivities that may lead to alternate clinical applications. For example, LY333'531, a PKCbeta inhibitor currently in phase III clinical trials, efficiently inhibited PIM1 kinase in our screen, a suggested target for treatment of leukemia. We determined the binding mode of this inhibitor by x-ray crystallography and in addition showed that LY333'531 induced cell death and significantly suppressed growth of leukemic cells from acute myeloid leukemia patients.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, United Kingdom.</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Pogacic</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>Rellos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="605" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/605"/></api:links><api:last-name>Bullock</api:last-name><api:initials>AN</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>SundstrÃ¶m</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/18077363</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.0708800104</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.0708800104"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.0708800104"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2154464</api:identifier></api:identifiers></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>51</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proc Natl Acad Sci U S A</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Binding Sites</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword><api:keyword scheme="mesh">Drug Evaluation, Preclinical</api:keyword><api:keyword scheme="mesh">Enzyme Stability</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Molecular Sequence Data</api:keyword><api:keyword scheme="mesh">Phylogeny</api:keyword><api:keyword scheme="mesh">Protein Array Analysis</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Protein Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Protein-Serine-Threonine Kinases</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>20523</api:begin-page><api:end-page>20528</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>0708800104</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>18</api:day><api:month>12</api:month><api:year>2007</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:18077363"><api:citation-count>85</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In addition, kinase inhibitors are widely used as specific probes to study cell signaling, but systematic studies describing selectivity of these reagents across a panel of diverse kinases are largely lacking. Here we evaluated the specificity of 156 validated kinase inhibitors, including inhibitors used in clinical trials, against 60 human Ser/Thr kinases using a thermal stability shift assay. Our analysis revealed many unexpected cross-reactivities for inhibitors thought to be specific for certain targets. We also found that certain combinations of active-site residues in the ATP-binding site correlated with the detected ligand promiscuity and that some kinases are highly sensitive to inhibition using diverse chemotypes, suggesting them as preferred intervention points. Our results uncovered also inhibitor cross-reactivities that may lead to alternate clinical applications. For example, LY333'531, a PKCbeta inhibitor currently in phase III clinical trials, efficiently inhibited PIM1 kinase in our screen, a suggested target for treatment of leukemia. We determined the binding mode of this inhibitor by x-ray crystallography and in addition showed that LY333'531 induced cell death and significantly suppressed growth of leukemic cells from acute myeloid leukemia patients.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Structural Genomics Consortium, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, United Kingdom.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="orcid">0000-0001-9004-1815</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Pogacic</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>Rellos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="605" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/605"/></api:links><api:last-name>Bullock</api:last-name><api:initials>AN</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>SundstrÃ¶m</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.0708800104</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.0708800104"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.0708800104"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">18077363</api:identifier><api:identifier scheme="pmc">PMC2154464</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>51</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proceedings of the National Academy of Sciences of the United States of America</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Protein-Serine-Threonine Kinases</api:keyword><api:keyword scheme="mesh">Protein Kinase Inhibitors</api:keyword><api:keyword scheme="mesh">Protein Array Analysis</api:keyword><api:keyword scheme="mesh">Drug Evaluation, Preclinical</api:keyword><api:keyword scheme="mesh">Enzyme Stability</api:keyword><api:keyword scheme="mesh">Phylogeny</api:keyword><api:keyword scheme="mesh">Binding Sites</api:keyword><api:keyword scheme="mesh">Amino Acid Sequence</api:keyword><api:keyword scheme="mesh">Protein Conformation</api:keyword><api:keyword scheme="mesh">Molecular Sequence Data</api:keyword><api:keyword scheme="mesh">Clinical Trials as Topic</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print-Electronic</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>20523</api:begin-page><api:end-page>20528</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>12</api:month><api:year>2007</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000251885000067"><api:citation-count>158</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:identifiers><api:identifier scheme="researcherid">B-6412-2014</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Pogacic</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>Rellos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Mueller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="605" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/605"/></api:links><api:last-name>Bullock</api:last-name><api:initials>AN</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Sundstrom</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Author URL"><api:text>http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;SrcApp=PARTNER_APP&amp;SrcAuth=LinksAMR&amp;KeyUT=000251885000067&amp;DestLinkType=FullRecord&amp;DestApp=ALL_WOS&amp;UsrCustomerID=4fd6f7d59a501f9b8bac2be37914c43e</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.0708800104</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.0708800104"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.0708800104"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">244SG</api:identifier><api:identifier scheme="pubmed">18077363</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>51</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>acute myeloid leukemia</api:keyword><api:keyword>inhibitor selectivity</api:keyword><api:keyword>LY333'531</api:keyword><api:keyword>PIM1</api:keyword><api:keyword>screening data</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>20523</api:begin-page><api:end-page>20528</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>18</api:day><api:month>12</api:month><api:year>2007</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-38049155899"><api:citation-count>167</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In addition, kinase inhibitors are widely used as specific probes to study cell signaling, but systematic studies describing selectivity of these reagents across a panel of diverse kinases are largely lacking. Here we evaluated the specificity of 156 validated kinase inhibitors, including inhibitors used in clinical trials, against 60 human Ser/Thr kinases using a thermal stability shift assay. Our analysis revealed many unexpected cross-reactivities for inhibitors thought to be specific for certain targets. We also found that certain combinations of active-site residues in the ATP-binding site correlated with the detected ligand promiscuity and that some kinases are highly sensitive to inhibition using diverse chemotypes, suggesting them as preferred intervention points. Our results uncovered also inhibitor cross-reactivities that may lead to alternate clinical applications. For example, LY333â²531, a PKCÎ² inhibitor currently in phase III clinical trials, efficiently inhibited PIM1 kinase in our screen, a suggested target for treatment of leukemia. We determined the binding mode of this inhibitor by x-ray crystallography and in addition showed that LY333â²531 induced cell death and significantly suppressed growth of leukemic cells from acute myeloid leukemia patients. Â© 2007 by The National Academy of Sciences of the USA.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9534869500</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>B</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">9536036000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Pogacic</api:last-name><api:initials>V</api:initials><api:addresses><api:address iso-country-code="CH"><api:line type="organisation">Laboratory for Childhood Leukemia</api:line><api:line type="organisation">Department of Research</api:line><api:line type="organisation">University Hospital Basel</api:line><api:line type="street-address">Hebelstrasse 20</api:line><api:line type="city">CH-4031 Basel</api:line><api:line type="country">che</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6507708606</api:identifier></api:identifiers></api:person><api:person><api:last-name>Rellos</api:last-name><api:initials>P</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">36961962500</api:identifier></api:identifiers></api:person><api:person><api:last-name>MÃ¼ller</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">56016515900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="605" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/605"/></api:links><api:last-name>Bullock</api:last-name><api:initials>AN</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005199331</api:identifier></api:identifiers></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials><api:addresses><api:address iso-country-code="CH"><api:line type="organisation">Laboratory for Childhood Leukemia</api:line><api:line type="organisation">Department of Research</api:line><api:line type="organisation">University Hospital Basel</api:line><api:line type="street-address">Hebelstrasse 20</api:line><api:line type="city">CH-4031 Basel</api:line><api:line type="country">che</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701597458</api:identifier></api:identifiers></api:person><api:person><api:last-name>SundstrÃ¶m</api:last-name><api:initials>M</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>michael.sundstrom@cpr.ku.dk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">56225198300</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Structural Genomics Consortium</api:line><api:line type="organisation">Botnar Research Centre</api:line><api:line type="organisation">University of Oxford</api:line><api:line type="city">Oxford OX3 7LD</api:line><api:line type="country">gbr</api:line></api:address></api:addresses><api:email-address>stefan.knapp@sgc.ox.ac.uk</api:email-address><api:identifiers><api:identifier scheme="scopus-author-id">7202675553</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.0708800104</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.0708800104"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.0708800104"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">18077363</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>51</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proceedings of the National Academy of Sciences of the United States of America</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Acute myeloid leukemia</api:keyword><api:keyword>Inhibitor selectivity</api:keyword><api:keyword>LY333â²531</api:keyword><api:keyword>PIM1</api:keyword><api:keyword>Screening data</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>20523</api:begin-page><api:end-page>20528</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>18</api:day><api:month>12</api:month><api:year>2007</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record><api:record format="native" source-id="13" source-name="crossref" source-display-name="CrossRef" id-at-source="10.1073/pnas.0708800104"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Fedorov</api:last-name><api:initials>O</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="609" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/609"/></api:links><api:last-name>Marsden</api:last-name><api:initials>B</api:initials></api:person><api:person><api:last-name>Pogacic</api:last-name><api:initials>V</api:initials></api:person><api:person><api:last-name>Rellos</api:last-name><api:initials>P</api:initials></api:person><api:person><api:last-name>Muller</api:last-name><api:initials>S</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="605" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/605"/></api:links><api:last-name>Bullock</api:last-name><api:initials>AN</api:initials></api:person><api:person><api:last-name>Schwaller</api:last-name><api:initials>J</api:initials></api:person><api:person><api:last-name>Sundstrom</api:last-name><api:initials>M</api:initials></api:person><api:person><api:links><api:link type="elements/user" id="608" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/users/608"/></api:links><api:last-name>Knapp</api:last-name><api:initials>S</api:initials></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1073/pnas.0708800104</api:text><api:links><api:link type="doi" href="http://dx.doi.org/10.1073/pnas.0708800104"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1073/pnas.0708800104"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1091-6490</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/1091-6490"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0027-8424</api:text><api:links><api:link type="elements/journal" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>51</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Proceedings of the National Academy of Sciences</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>aa</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>20523</api:begin-page><api:end-page>20528</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>18</api:day><api:month>12</api:month><api:year>2007</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>104</api:text></api:field></api:native></api:record></api:records><api:fields/><api:journal issn="0027-8424" href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/journals/0027-8424"><api:records><api:record source-name="era2012"><api:title>Proceedings of the National Academy of Sciences of USA</api:title></api:record><api:record source-name="snip"><api:title>Proceedings of the National Academy of Sciences of the United States of America</api:title></api:record><api:record source-name="era2010"><api:title>Proceedings of the National Academy of Sciences of USA</api:title></api:record><api:record source-name="sherpa-romeo"><api:title>Proceedings of the National Academy of Sciences</api:title></api:record></api:records></api:journal><api:relationships href="https://oxris.ox.ac.uk:8091/elements-api/v4.9/publications/34076/relationships"/></api:object></api:related></api:relationship></entry></feed>